PepsiCo (PEP) 10-Q 7 Oct 24 2024 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	8 Months Ended
	Sep. 07, 2024	Oct. 01, 2024
Document and Entity Information [Line Items]
Document Type	10-Q
Document Period End Date	Sep. 07, 2024
Entity File Number	1-1183
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Registrant Name	PepsiCo, Inc.
Entity Incorporation, State or Country Code	NC
Entity Address, City or Town	Purchase
Entity Address, State or Province	NY
Entity Tax Identification Number	13-1584302
Entity Address, Address Line One	700 Anderson Hill Road
Entity Address, Postal Zip Code	10577
City Area Code	914
Local Phone Number	253-2000
Entity Common Stock, Shares Outstanding		1,371,989,025
Entity Central Index Key	0000077476
Current Fiscal Year End Date	--12-28
Document Fiscal Year Focus	2024
Entity Filer Category	Large Accelerated Filer
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Common Stock
Document and Entity Information [Line Items]
Title of 12(b) Security	Common Stock, par value 1-2/3 cents per share
Trading Symbol	PEP
Name of Exchange on which Security is Registered	NASDAQ
2.625% Senior Notes Due 2026
Document and Entity Information [Line Items]
Title of 12(b) Security	2.625% Senior Notes Due 2026
Trading Symbol	PEP26
Name of Exchange on which Security is Registered	NASDAQ
0.750% Senior Notes Due 2027
Document and Entity Information [Line Items]
Title of 12(b) Security	0.750% Senior Notes Due 2027
Trading Symbol	PEP27
Name of Exchange on which Security is Registered	NASDAQ
0.875% Senior Notes Due 2028
Document and Entity Information [Line Items]
Title of 12(b) Security	0.875% Senior Notes Due 2028
Trading Symbol	PEP28
Name of Exchange on which Security is Registered	NASDAQ
0.500% Senior Notes Due 2028
Document and Entity Information [Line Items]
Title of 12(b) Security	0.500% Senior Notes Due 2028
Trading Symbol	PEP28A
Name of Exchange on which Security is Registered	NASDAQ
3.200% Senior Notes Due 2029
Document and Entity Information [Line Items]
Title of 12(b) Security	3.200% Senior Notes Due 2029
Trading Symbol	PEP29
Name of Exchange on which Security is Registered	NASDAQ
1.125% Senior Notes Due 2031
Document and Entity Information [Line Items]
Title of 12(b) Security	1.125% Senior Notes Due 2031
Trading Symbol	PEP31
Name of Exchange on which Security is Registered	NASDAQ
0.400% Senior Notes Due 2032
Document and Entity Information [Line Items]
Title of 12(b) Security	0.400% Senior Notes Due 2032
Trading Symbol	PEP32
Name of Exchange on which Security is Registered	NASDAQ
0.750% Senior Notes Due 2033
Document and Entity Information [Line Items]
Title of 12(b) Security	0.750% Senior Notes Due 2033
Trading Symbol	PEP33
Name of Exchange on which Security is Registered	NASDAQ
3.550% Senior Notes Due 2034
Document and Entity Information [Line Items]
Title of 12(b) Security	3.550% Senior Notes Due 2034
Trading Symbol	PEP34
Name of Exchange on which Security is Registered	NASDAQ
0.875% Senior Notes Due 2039
Document and Entity Information [Line Items]
Title of 12(b) Security	0.875% Senior Notes Due 2039
Trading Symbol	PEP39
Name of Exchange on which Security is Registered	NASDAQ
1.050% Senior Notes Due 2050
Document and Entity Information [Line Items]
Title of 12(b) Security	1.050% Senior Notes Due 2050
Trading Symbol	PEP50
Name of Exchange on which Security is Registered	NASDAQ

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended		8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Net Revenue	$ 23,319	$ 23,453	$ 64,070	$ 63,621
Cost of sales	10,396	10,675	28,563	28,784
Gross profit	12,923	12,778	35,507	34,837
Selling, general and administrative expenses	9,051	8,763	24,870	24,534
Operating Profit	3,872	4,015	10,637	10,303
Other pension and retiree medical benefits income	41	62	155	183
Net interest expense and other	(219)	(201)	(655)	(602)
Income before income taxes	3,694	3,876	10,137	9,884
Provision for income taxes	749	760	2,045	2,053
Net income	2,945	3,116	8,092	7,831
Net Income (Loss) Attributable to Noncontrolling Interest	15	24	37	59
Net Income Attributable to PepsiCo	$ 2,930	$ 3,092	$ 8,055	$ 7,772
Earnings Per Share [Abstract]
Earnings Per Share, Basic (in USD per share)	$ 2.13	$ 2.25	$ 5.86	$ 5.64
Earnings Per Share, Diluted (in USD per share)	$ 2.13	$ 2.24	$ 5.84	$ 5.62
Weighted-average common shares outstanding
Weighted Average Number of Shares Outstanding, Basic (in shares)	1,373	1,376	1,374	1,377
Weighted Average Number of Shares Outstanding, Diluted (in shares)	1,378	1,383	1,379	1,384

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 2,945	$ 3,116	$ 8,092	$ 7,831
Net currency translation adjustment	(512)	2	(961)	(431)
Net change on cash flow hedges	(24)	(11)	21	(46)
Net pension and retiree medical adjustments	21	(8)	41	(18)
Net change on available-for-sale debt securities and other	(351)	3	(219)	3
Other comprehensive loss, net of taxes:	(866)	(14)	(1,118)	(492)
Comprehensive income	2,079	3,102	6,974	7,339
Less: Comprehensive income attributable to noncontrolling interests	15	24	37	59
Comprehensive Income Attributable to PepsiCo	$ 2,064	$ 3,078	$ 6,937	$ 7,280

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023
Operating Activities
Net income	$ 8,092	$ 7,831
Depreciation and amortization	2,118	1,973
Impairment and other (credits)/charges	10	102
Product recall-related impact	184	0
Operating lease right-of-use asset amortization	438	384
Share-based compensation expense	260	267
Restructuring and impairment charges	415	287
Cash payments for restructuring charges	(284)	(283)
Payments for product recall-related impact	(138)	0
Pension and retiree medical plan expenses	114	93
Pension and retiree medical plan contributions	(300)	(374)
Deferred income taxes and other tax charges and credits	124	343
Tax payments related to the Tax Cuts and Jobs Act (TCJ Act)	(579)	(309)
Change in assets and liabilities:
Accounts and notes receivable	(1,521)	(1,699)
Inventories	(492)	(473)
Prepaid expenses and other current assets	(200)	(242)
Accounts payable and other current liabilities	(2,312)	(859)
Income taxes payable	426	512
Other, net	(135)	77
Net Cash Provided by Operating Activities	6,220	7,630
Investing Activities
Capital spending	(2,850)	(2,537)
Sales of property, plant and equipment	177	131
Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets	(31)	(132)
Other divestitures, sales of investments in noncontrolled affiliates and other assets	145	75
Short-term investments, by original maturity:
More than three months - purchases	(425)	(555)
More than three months - maturities	0	554
Proceeds from Sale of Debt Securities, Available-for-Sale	0	12
Three months or less, net	4	24
Other investing, net	15	49
Net Cash Used for Investing Activities	(2,965)	(2,379)
Financing Activities
Proceeds from issuances of long-term debt	4,014	2,986
Payments of long-term debt	(2,883)	(2,253)
Short-term borrowings, by original maturity:
More than three months - proceeds	3,808	4,688
More than three months - payments	(4,177)	(1,037)
Three months or less, net	101	1,395
Cash dividends paid	(5,369)	(4,941)
Share repurchases	(760)	(751)
Proceeds from exercises of stock options	138	100
Withholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted	(132)	(135)
Other financing	(22)	(18)
Net Cash (Used for)/Provided by Financing Activities	(5,282)	34
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(391)	(254)
Net (Decrease)/Increase in Cash and Cash Equivalents and Restricted Cash	(2,418)	5,031
Cash and Cash Equivalents and Restricted Cash, Beginning of Year	9,761	5,100
Cash and Cash Equivalents and Restricted Cash, End of Period	7,343	10,131
Supplemental Non-Cash Activity
Right-of-use assets obtained in exchange for lease obligations	869	705
Debt discharged via legal defeasance	$ 0	$ 94

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEET - USD ($) shares in Millions, $ in Millions	Sep. 07, 2024	Dec. 30, 2023
Current Assets
Cash and cash equivalents	$ 7,308	$ 9,711
Short-term investments	743	292
Accounts and Financing Receivable, after Allowance for Credit Loss, Current	12,088	10,815
Inventories:
Raw materials and packaging	2,559	2,388
Work-in-process	131	104
Finished goods	2,954	2,842
Inventory, Net, Total	5,644	5,334
Prepaid expenses and other current assets	1,069	798
Total Current Assets	26,852	26,950
Property, plant and equipment	55,466	54,439
Accumulated depreciation	(28,278)	(27,400)
Property, Plant and Equipment, net	27,188	27,039
Amortizable Intangible Assets, net	1,132	1,199
Goodwill	17,709	17,728
Other Indefinite-Lived Intangible Assets	13,725	13,730
Investments in Noncontrolled Affiliates	2,645	2,714
Deferred Income Taxes	4,321	4,474
Other Assets	6,941	6,661
Total Assets	100,513	100,495
Current Liabilities
Short-term debt obligations	6,524	6,510
Accounts payable and other current liabilities	23,791	25,137
Total Current Liabilities	30,315	31,647
Long-Term Debt Obligations	38,490	37,595
Deferred Income Taxes	3,684	3,895
Other Liabilities	8,419	8,721
Total Liabilities	$ 80,908	$ 81,858
Common stock, issued (in shares)	1,373	1,374
PepsiCo Common Shareholders’ Equity
Common stock, par value 12/3¢ per share (authorized 3,600 shares; issued, net of repurchased common stock at par value: 1,373 and 1,374 shares, respectively)	$ 23	$ 23
Capital in excess of par value	4,281	4,261
Retained earnings	72,607	70,035
Accumulated other comprehensive loss	(16,652)	(15,534)
Repurchased common stock, in excess of par value (494 and 493 shares, respectively)	(40,806)	(40,282)
Total PepsiCo Common Shareholders’ Equity	19,453	18,503
Noncontrolling interests	152	134
Total Equity	19,605	18,637
Total Liabilities and Equity	$ 100,513	$ 100,495
Treasury Stock, Common, Shares	494	493

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEET (Parenthetical) - USD ($) shares in Thousands, $ in Millions	Sep. 07, 2024	Dec. 30, 2023
Statement of Financial Position [Abstract]
Accounts and notes receivable, allowance	$ 166	$ 175
Common stock, par value (in USD per share)	$ 0.0167	$ 0.0167
Common stock, authorized (in shares)	3,600,000	3,600,000
Common stock, issued (in shares)	1,373,000	1,374,000
Treasury Stock, Common, Shares	494,000	493,000

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENT OF EQUITY - USD ($) shares in Millions, $ in Millions		Total	Common Stock	Capital in Excess of Par Value	Retained Earnings	Accumulated Other Comprehensive Loss	Total PepsiCo Common Shareholders’ Equity	Noncontrolling Interests	Treasury Stock, Common
Common stock, dividends, declared (in USD per share)		$ 3.68
Balance, beginning of period, shares (in shares) at Dec. 31, 2022			1,377
Balance, beginning of period at Dec. 31, 2022			$ 23	$ 4,134	$ 67,800	$ (15,302)		$ 124	$ (39,506)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Changes in repurchased common stock (in shares)			(2)						(5)
Change in repurchased common stock			$ 0
Share-based compensation expense				267
Stock option exercises, RSUs and PSUs converted				(108)					$ 208
Withholding tax on RSUs and PSUs converted				(135)
Other				(4)
Net income attributable to PepsiCo		$ 7,772			7,772
Cash dividends declared - common	[1]				(5,093)
Other comprehensive loss attributable to PepsiCo						(492)
Balance, beginning of period, shares issued (in shares) at Dec. 31, 2022									(490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock option exercises, RSUs and PSUs converted (in shares)									3
Other (in shares)									0
Share repurchases									$ (759)
Balance, end of period, shares issued (in shares) at Sep. 09, 2023									(492)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income attributable to noncontrolling interest		59						59
Distributions to noncontrolling interests								(15)
Other, net								(4)	$ 1
Balance, end of period, shares (in shares) at Sep. 09, 2023			1,375
Balance, end of period at Sep. 09, 2023		$ 18,970	$ 23	4,154	70,479	(15,794)	$ 18,806	164	(40,056)
Common stock, dividends, declared (in USD per share)		$ 1.265
Balance, beginning of period, shares (in shares) at Jun. 17, 2023			1,377
Balance, beginning of period at Jun. 17, 2023			$ 23	4,082	69,135	(15,780)		140	$ (39,775)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Changes in repurchased common stock (in shares)			(2)						(2)
Change in repurchased common stock			$ 0
Share-based compensation expense				88
Stock option exercises, RSUs and PSUs converted				3					$ 11
Withholding tax on RSUs and PSUs converted				(16)
Other				(3)
Net income attributable to PepsiCo		$ 3,092			3,092
Cash dividends declared - common	[1]				(1,748)
Other comprehensive loss attributable to PepsiCo						(14)
Balance, beginning of period, shares issued (in shares) at Jun. 17, 2023									(490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock option exercises, RSUs and PSUs converted (in shares)									0
Other (in shares)									0
Share repurchases									$ (293)
Balance, end of period, shares issued (in shares) at Sep. 09, 2023									(492)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income attributable to noncontrolling interest		24						24
Distributions to noncontrolling interests								0
Other, net								0	$ 1
Balance, end of period, shares (in shares) at Sep. 09, 2023			1,375
Balance, end of period at Sep. 09, 2023		$ 18,970	$ 23	4,154	70,479	(15,794)	18,806	164	(40,056)
Common stock, dividends, declared (in USD per share)		$ 3.975
Balance, beginning of period, shares (in shares) at Dec. 30, 2023			1,374
Balance, beginning of period at Dec. 30, 2023		$ 18,637	$ 23	4,261	70,035	(15,534)		134	$ (40,282)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Changes in repurchased common stock (in shares)			(1)						(5)
Change in repurchased common stock			$ 0
Share-based compensation expense				255
Stock option exercises, RSUs and PSUs converted				(95)					$ 233
Withholding tax on RSUs and PSUs converted				(132)
Other				(8)
Net income attributable to PepsiCo		8,055			8,055
Cash dividends declared - common	[1]				(5,483)
Other comprehensive loss attributable to PepsiCo						(1,118)
Balance, beginning of period, shares issued (in shares) at Dec. 30, 2023									(493)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock option exercises, RSUs and PSUs converted (in shares)									4
Other (in shares)									0
Share repurchases									$ (762)
Balance, end of period, shares issued (in shares) at Sep. 07, 2024									(494)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income attributable to noncontrolling interest		37						37
Distributions to noncontrolling interests								(17)
Other, net								(2)	$ 5
Balance, end of period, shares (in shares) at Sep. 07, 2024			1,373
Balance, end of period at Sep. 07, 2024		$ 19,605	$ 23	4,281	72,607	(16,652)	19,453	152	(40,806)
Common stock, dividends, declared (in USD per share)		$ 1.355
Balance, beginning of period, shares (in shares) at Jun. 15, 2024			1,374
Balance, beginning of period at Jun. 15, 2024			$ 23	4,203	71,545	(15,786)		134	$ (40,539)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Changes in repurchased common stock (in shares)			(1)						(2)
Change in repurchased common stock			$ 0
Share-based compensation expense				76
Stock option exercises, RSUs and PSUs converted				9					$ 23
Withholding tax on RSUs and PSUs converted				(1)
Other				(6)
Net income attributable to PepsiCo		$ 2,930			2,930
Cash dividends declared - common	[1]				(1,868)
Other comprehensive loss attributable to PepsiCo						(866)
Balance, beginning of period, shares issued (in shares) at Jun. 15, 2024									(493)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock option exercises, RSUs and PSUs converted (in shares)									1
Other (in shares)									0
Share repurchases									$ (294)
Balance, end of period, shares issued (in shares) at Sep. 07, 2024									(494)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income attributable to noncontrolling interest		15						15
Distributions to noncontrolling interests								0
Other, net								3	$ 4
Balance, end of period, shares (in shares) at Sep. 07, 2024			1,373
Balance, end of period at Sep. 07, 2024		$ 19,605	$ 23	$ 4,281	$ 72,607	$ (16,652)	$ 19,453	$ 152	$ (40,806)
[1] Cash dividends declared per common share were $1.355 and $1.265 for the 12 weeks ended September 7, 2024 and September 9, 2023, respectively, and $3.975 and $3.68 for the 36 weeks ended September 7, 2024 and September 9, 2023, respectively.

Basis of Presentation and Our D

Basis of Presentation and Our Divisions	8 Months Ended
	Sep. 07, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Other Divisions	Basis of Presentation and Our Divisions Basis of Presentation When used in this report, the terms “we,” “us,” “our,” “PepsiCo” and the “Company” mean PepsiCo, Inc. and its consolidated subsidiaries, collectively. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP) for interim financial information and with the rules and regulations for reporting the Quarterly Report on Form 10-Q (Form 10-Q). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The condensed consolidated balance sheet at December 30, 2023 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements. These financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in our Annual Report on Form 10-K for the fiscal year ended December 30, 2023 (2023 Form 10-K). This report should be read in conjunction with our 2023 Form 10-K. In our opinion, these financial statements include all normal and recurring adjustments necessary for a fair presentation. The results for the 12 and 36 weeks ended September 7, 2024 are not necessarily indicative of the results expected for any future period or the full year. Raw materials, direct labor and plant overhead, as well as purchasing and receiving costs, costs directly related to production planning, inspection costs and raw materials handling facilities, are included in cost of sales. The costs of moving, storing and delivering finished product, including merchandising activities, are included in selling, general and administrative expenses. While our financial results in the United States and Canada (North America) are reported on a 12-week basis, all of our international operations are reported on a monthly calendar basis for which the months of June, July and August are reflected in our results for the 12 weeks ended September 7, 2024 and September 9, 2023, and the months of January through August are reflected in our results for the 36 weeks ended September 7, 2024 and September 9, 2023. The preparation of our condensed consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and related disclosures. Additionally, the business and economic uncertainty resulting from volatile geopolitical conditions and changes in the interest rate and inflationary cost environment have made such estimates and assumptions more difficult to calculate. Accordingly, actual results and outcomes could differ from those estimates. Our significant interim accounting policies include the recognition of a pro rata share of certain estimated annual sales incentives and certain advertising and marketing costs in proportion to revenue or volume, as applicable, and the recognition of income taxes using an estimated annual effective tax rate. Unless otherwise noted, tabular dollars are in millions, except per share amounts. All per share amounts reflect common per share amounts, assume dilution unless otherwise noted, and are based on unrounded amounts. Certain reclassifications were made to the prior year’s financial statements to conform to the current year presentation. Our Divisions We are organized into seven reportable segments (also referred to as divisions), as follows: 1) Frito-Lay North America (FLNA), which includes our branded convenient food businesses in the United States and Canada; 2) Quaker Foods North America (QFNA), which includes our branded convenient food businesses, such as cereal, rice, pasta and other branded food, in the United States and Canada; 3) PepsiCo Beverages North America (PBNA), which includes our beverage businesses in the United States and Canada; 4) Latin America (LatAm), which includes all of our beverage and convenient food businesses in Latin America; 5) Europe, which includes all of our beverage and convenient food businesses in Europe; 6) Africa, Middle East and South Asia (AMESA), which includes all of our beverage and convenient food businesses in Africa, the Middle East and South Asia; and 7) Asia Pacific, Australia and New Zealand and China region (APAC), which includes all of our beverage and convenient food businesses in Asia Pacific, Australia and New Zealand, and China region. Net revenue of each division is as follows: 12 Weeks Ended 36 Weeks Ended 9/7/2024 9/9/2023 9/7/2024 9/9/2023 FLNA $ 5,888 $ 5,954 $ 17,438 $ 17,441 QFNA 648 747 1,802 2,208 PBNA 7,175 7,161 19,860 19,714 LatAm 2,915 3,055 8,027 7,688 Europe 3,946 3,704 9,397 9,018 AMESA 1,552 1,615 4,184 4,202 APAC 1,195 1,217 3,362 3,350 Total $ 23,319 $ 23,453 $ 64,070 $ 63,621 Our primary performance obligation is the distribution and sales of beverage and convenient food products to our customers. The following tables reflect the percentage of net revenue generated between our beverage business and our convenient food business for each of our international divisions, as well as our consolidated net revenue: 12 Weeks Ended 9/7/2024 9/9/2023 Beverages (a) Convenient Foods Beverages (a) Convenient Foods LatAm 10 % 90 % 10 % 90 % Europe 51 % 49 % 50 % 50 % AMESA 31 % 69 % 31 % 69 % APAC 26 % 74 % 27 % 73 % PepsiCo 44 % 56 % 43 % 57 % 36 Weeks Ended 9/7/2024 9/9/2023 Beverages (a) Convenient Foods Beverages (a) Convenient Foods LatAm 10 % 90 % 9 % 91 % Europe 48 % 52 % 49 % 51 % AMESA 32 % 68 % 31 % 69 % APAC 23 % 77 % 23 % 77 % PepsiCo 43 % 57 % 42 % 58 % (a) Beverage revenue from company-owned bottlers, which primarily includes our consolidated bottling operations in our PBNA and Europe divisions, was 37% and 36% of our consolidated net revenue in the 12 and 36 weeks ended September 7, 2024, respectively, and 36% of our consolidated net revenue in the 12 and 36 weeks ended September 9, 2023. Generally, our finished goods beverage operations produce higher net revenue but lower operating margin as compared to concentrate sold to authorized bottling partners for the manufacture of finished goods beverages. Operating profit of each division is as follows: 12 Weeks Ended 36 Weeks Ended 9/7/2024 9/9/2023 9/7/2024 9/9/2023 FLNA $ 1,523 $ 1,669 $ 4,669 $ 4,915 QFNA (a) 97 135 133 452 PBNA (b) 914 970 2,411 2,176 LatAm 595 593 1,717 1,549 Europe 728 659 1,550 1,206 AMESA 197 238 590 656 APAC 262 239 718 689 Total divisions 4,316 4,503 11,788 11,643 Corporate unallocated expenses (c) (444) (488) (1,151) (1,340) Total $ 3,872 $ 4,015 $ 10,637 $ 10,303 (a) In the 36 weeks ended September 7, 2024, we recorded a pre-tax charge of $184 million ($141 million after-tax or $0.10 per share) associated with a previously announced voluntary recall of certain bars and cereals in our QFNA division (Quaker Recall) with $174 million recorded in cost of sales related to property, plant and equipment write-offs, employee severance costs and other costs, $7 million recorded in selling, general and administrative expenses and $3 million recorded in other pension and retiree medical benefits income, which is not included in operating profit. (b) In the 36 weeks ended September 9, 2023, we recorded our proportionate 39% share of Tropicana Brands Group’s (TBG) impairment of indefinite-lived intangible assets, and recorded an other-than-temporary impairment of our equity method investment, both of which resulted in pre-tax impairment charges of $113 million ($86 million after-tax or $0.06 per share), recorded in selling, general and administrative expenses. See Note 9 for further information. (c) In the 36 weeks ended September 7, 2024 and September 9, 2023, we recorded a pre-tax gain of $76 million ($57 million after-tax or $0.04 per share) and $85 million ($65 million after-tax or $0.05 per share), respectively, in selling, general and administrative expenses as a result of the sale of corporate assets.

Recently Issued Accounting Pron

Recently Issued Accounting Pronouncements (Notes)	8 Months Ended
	Sep. 07, 2024
Accounting Changes and Error Corrections [Abstract]
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Adopted In September 2022, the Financial Accounting Standards Board (FASB) issued guidance to enhance the transparency of supplier finance programs to allow financial statement users to understand the effect on working capital, liquidity and cash flows. The new guidance requires disclosure of key terms of the program, including a description of the payment terms, payment timing and assets pledged as security or other forms of guarantees provided to the finance provider or intermediary. Other requirements include the disclosure of the amount that remains unpaid as of the end of the reporting period, a description of where these obligations are presented in the balance sheet and a rollforward of the obligation during the annual period. We adopted the guidance in the first quarter of 2023, except for the rollforward, which is effective for the current fiscal year 2024. We will adopt the rollforward guidance when it becomes effective in our 2024 annual reporting, on a prospective basis. See Note 12 for disclosures currently required under this guidance. Not Yet Adopted In December 2023, the FASB issued guidance to enhance transparency of income tax disclosures. On an annual basis, the new guidance requires a public entity to disclose: (1) specific categories in the rate reconciliation, (2) additional information for reconciling items that are equal to or greater than 5% of the amount computed by multiplying income (or loss) from continuing operations before income tax expense (or benefit) by the applicable statutory income tax rate, (3) income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes, with foreign taxes disaggregated by individual jurisdictions in which income taxes paid is equal to or greater than 5% of total income taxes paid, (4) income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and (5) income tax expense (or benefit) from continuing operations disaggregated between federal (national), state and foreign. The guidance is effective for fiscal year 2025 annual reporting, with early adoption permitted, to be applied on a prospective basis, with retrospective application permitted. We will adopt the guidance when it becomes effective, in our 2025 annual reporting, on a prospective basis. In November 2023, the FASB issued guidance to enhance disclosure of expenses of a public entity’s reportable segments. The new guidance requires a public entity to disclose: (1) on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker (CODM) and included within each reported measure of segment profit or loss, (2) on an annual and interim basis, an amount for other segment items (the difference between segment revenue less the significant expenses disclosed under the significant expense principle and each reported measure of segment profit or loss), including a description of its composition, (3) on an annual and interim basis, information about a reportable segment’s profit or loss and assets previously required to be disclosed only on an annual basis, and (4) the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and how to allocate resources. The new guidance also clarifies that if the CODM uses more than one measure of a segment’s profit or loss, one or more of those measures may be reported and requires that a public entity that has a single reportable segment provide all the disclosures required by the amendments in this update and all existing segment disclosures. The guidance is effective for the current fiscal year 2024 annual reporting, and in the first quarter of 2025 for interim period reporting, with early adoption permitted. Upon adoption, this guidance should be applied retrospectively to all prior periods presented. We will adopt the guidance when it becomes effective in our 2024 annual reporting.

Restructuring and Impairment Ch

Restructuring and Impairment Charges	8 Months Ended
	Sep. 07, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Impairment Charges	Restructuring and Impairment Charges 2019 Multi-Year Productivity Plan We publicly announced a multi-year productivity plan on February 15, 2019 (2019 Productivity Plan) that leverages new technology and business models to further simplify, harmonize and automate processes; re-engineers our go-to-market and information systems, including deploying the right automation for each market; and simplifies our organization and optimizes our manufacturing and supply chain footprint. To build on the successful implementation of the 2019 Productivity Plan, in 2022, we expanded and extended the plan through the end of 2028 to take advantage of additional opportunities within the initiatives described above. As a result, we expect to incur pre-tax charges of approximately $3.65 billion, including cash expenditures of approximately $2.9 billion. These pre-tax charges are expected to consist of approximately 55% of severance and other employee-related costs, 10% for asset impairments (all non-cash) resulting from plant closures and related actions, and 35% for other costs associated with the implementation of our initiatives. The total plan pre-tax charges are expected to be incurred by division approximately as follows: FLNA QFNA PBNA LatAm Europe AMESA APAC Corporate Expected pre-tax charges 10 % 1 % 30 % 10 % 25 % 5 % 4 % 15 % A summary of our 2019 Productivity Plan charges is as follows: 12 Weeks Ended 36 Weeks Ended 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Cost of sales $ 10 $ 4 $ 16 $ 10 Selling, general and administrative expenses 228 79 377 278 Other pension and retiree medical benefits expense/(income) (a) 7 — 22 (1) Total restructuring and impairment charges $ 245 $ 83 $ 415 $ 287 After-tax amount $ 195 $ 67 $ 325 $ 228 Impact on net income attributable to PepsiCo per common share $ (0.14) $ (0.05) $ (0.24) $ (0.16) 12 Weeks Ended 36 Weeks Ended Plan-to-Date 9/7/2024 9/9/2023 9/7/2024 9/9/2023 through 9/7/2024 FLNA $ 8 $ 6 $ 43 $ 19 $ 295 QFNA — — 4 — 23 PBNA 128 8 143 18 410 LatAm 11 8 32 19 232 Europe 46 44 83 185 649 AMESA 4 5 7 10 104 APAC 2 2 6 7 91 Corporate 39 10 75 30 392 238 83 393 288 2,196 Other pension and retiree medical benefits expense/(income) (a) 7 — 22 (1) 119 Total $ 245 $ 83 $ 415 $ 287 $ 2,315 (a) Income amount represents adjustments for changes in estimates of previously recorded amounts. 12 Weeks Ended 36 Weeks Ended Plan-to-Date 9/7/2024 9/9/2023 9/7/2024 9/9/2023 through 9/7/2024 Severance and other employee costs $ 151 $ 39 $ 233 $ 181 $ 1,283 Asset impairments 30 1 34 1 226 Other costs 64 43 148 105 806 Total $ 245 $ 83 $ 415 $ 287 $ 2,315 Severance and other employee costs primarily include severance and other termination benefits, as well as voluntary separation arrangements. Other costs primarily include costs associated with the implementation of our initiatives, including consulting and other professional fees, as well as contract termination costs. A summary of our 2019 Productivity Plan activity for the 36 weeks ended September 7, 2024 is as follows: Severance and Other Employee Costs Asset Other Costs Total Liability as of December 30, 2023 $ 188 $ — $ 9 $ 197 2024 restructuring charges 233 34 148 415 Cash payments (131) — (153) (284) Non-cash charges and translation (17) (34) 22 (29) Liability as of September 7, 2024 $ 273 $ — $ 26 $ 299 Substantially all of the restructuring accrual at September 7, 2024 is expected to be paid by the end of 2025. Other Productivity Initiatives There were no material charges related to other productivity and efficiency initiatives outside the scope of the 2019 Productivity Plan. We regularly evaluate different productivity initiatives beyond the productivity plan and other initiatives described above.

Intangible Assets

Intangible Assets	8 Months Ended
	Sep. 07, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets A summary of our amortizable intangible assets is as follows: 9/7/2024 12/30/2023 Gross Accumulated Amortization Net Gross Accumulated Amortization Net Acquired franchise rights $ 836 $ (224) $ 612 $ 840 $ (214) $ 626 Customer relationships 561 (284) 277 560 (265) 295 Brands 1,087 (996) 91 1,093 (989) 104 Other identifiable intangibles 428 (276) 152 449 (275) 174 Total $ 2,912 $ (1,780) $ 1,132 $ 2,942 $ (1,743) $ 1,199 The change in the book value of indefinite-lived intangible assets is as follows: Balance 12/30/2023 Translation Balance 9/7/2024 FLNA Goodwill $ 453 $ (2) $ 451 Brands 251 — 251 Total 704 (2) 702 QFNA Goodwill 189 — 189 Total 189 — 189 PBNA Goodwill 11,961 (8) 11,953 Reacquired franchise rights 7,114 (14) 7,100 Acquired franchise rights 1,737 (3) 1,734 Brands 2,508 — 2,508 Total 23,320 (25) 23,295 LatAm Goodwill 460 (29) 431 Brands 82 (6) 76 Total 542 (35) 507 Europe Goodwill 3,166 3 3,169 Reacquired franchise rights 419 2 421 Acquired franchise rights 154 (10) 144 Brands 1,124 20 1,144 Total 4,863 15 4,878 AMESA Goodwill 991 17 1,008 Brands 137 6 143 Total 1,128 23 1,151 APAC Goodwill 508 — 508 Brands 204 — 204 Total 712 — 712 Total goodwill 17,728 (19) 17,709 Total reacquired franchise rights 7,533 (12) 7,521 Total acquired franchise rights 1,891 (13) 1,878 Total brands 4,306 20 4,326 Total $ 31,458 $ (24) $ 31,434

Income Taxes

Income Taxes	8 Months Ended
	Sep. 07, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Numerous countries have agreed to a statement in support of the Organization for Economic Co-operation and Development (OECD) model rules that propose a global minimum tax rate of 15%. Certain countries have enacted legislation incorporating the agreed global minimum tax effective in 2024. Legislation incorporating the agreed global minimum tax enacted as of September 7, 2024 did not have a material impact on our financial statements for the 12 and 36 weeks ended September 7, 2024 and is not expected to have a material impact on our 2024 financial statements.

Share-Based Compensation

Share-Based Compensation	8 Months Ended
	Sep. 07, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Share-Based Compensation The following table summarizes our total share-based compensation expense, which is primarily recorded in selling, general and administrative expenses: 12 Weeks Ended 36 Weeks Ended 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Share-based compensation expense – equity awards $ 77 $ 88 $ 260 $ 267 Share-based compensation expense – liability awards 4 7 14 19 Restructuring charges (1) — (5) — Total $ 80 $ 95 $ 269 $ 286 The following table summarizes share-based awards granted under the terms of the PepsiCo, Inc. Long-Term Incentive Plan: 36 Weeks Ended 9/7/2024 9/9/2023 Granted (a) Weighted-Average Grant Price Granted (a) Weighted-Average Grant Price Stock options 2.0 $ 164.28 2.1 $ 171.83 RSUs and PSUs 2.3 $ 164.25 2.1 $ 171.11 (a) In millions. All grant activity is disclosed at target. We granted long-term cash awards to certain executive officers and other senior executives with an aggregate target value of $19 million and $20 million during the 36 weeks ended September 7, 2024 and September 9, 2023, respectively. For the 12 weeks ended September 7, 2024 and September 9, 2023, our grants of stock options, RSUs, PSUs and long-term cash awards were nominal. Our weighted-average Black-Scholes fair value assumptions are as follows: 36 Weeks Ended 9/7/2024 9/9/2023 Expected life 7 years 7 years Risk-free interest rate 4.2 % 4.2 % Expected volatility 16 % 16 % Expected dividend yield 2.9 % 2.7 %

Pension and Retiree Medical Ben

Pension and Retiree Medical Benefits (Notes)	8 Months Ended
	Sep. 07, 2024
Pension and Retiree Medical Benefits [Abstract]
Pension and Retiree Medical Benefits	Pension and Retiree Medical Benefits The components of net periodic benefit cost/(income) for pension and retiree medical plans are as follows: 12 Weeks Ended Pension Retiree Medical U.S. International 9/7/2024 9/9/2023 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Service cost $ 80 $ 76 $ 11 $ 10 $ 7 $ 7 Other pension and retiree medical benefits income: Interest cost 135 137 36 34 7 7 Expected return on plan assets (201) (197) (50) (45) (3) (3) Amortization of prior service credits (6) (6) — (1) (1) (1) Amortization of net losses/(gains) 17 16 6 3 (6) (6) Settlement losses 8 — 7 — — — Special termination benefits 8 — — — 2 — Total other pension and retiree medical benefits income (39) (50) (1) (9) (1) (3) Total $ 41 $ 26 $ 10 $ 1 $ 6 $ 4 36 Weeks Ended Pension Retiree Medical U.S. International 9/7/2024 9/9/2023 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Service cost $ 240 $ 227 $ 32 $ 28 $ 22 $ 20 Other pension and retiree medical benefits income: Interest cost 405 411 99 93 22 24 Expected return on plan assets (604) (590) (139) (126) (9) (9) Amortization of prior service credits (17) (18) (1) (1) (3) (4) Amortization of net losses/(gains) 53 48 15 8 (18) (18) Settlement losses 8 — 9 — — — Special termination benefits 23 (1) — — 2 — Total other pension and retiree medical benefits income (132) (150) (17) (26) (6) (7) Total $ 108 $ 77 $ 15 $ 2 $ 16 $ 13 We regularly evaluate opportunities to reduce risk and volatility associated with our pension and retiree medical plans.

Debt Obligations

Debt Obligations	8 Months Ended
	Sep. 07, 2024
Debt Disclosure [Abstract]
Debt Disclosure	Debt Obligations In the 36 weeks ended September 7, 2024, we issued the following notes: Interest Rate Maturity Date Principal Amount (a) Floating rate February 2027 $ 300 (b) 4.650 % February 2027 $ 550 (b) 4.550 % February 2029 $ 450 (b) 4.700 % February 2034 $ 450 (b) 4.500 % July 2029 $ 850 4.800 % July 2034 $ 650 5.250 % July 2054 $ 750 (a) Excludes debt issuance costs, discounts and premiums. (b) Issued through our wholly-owned consolidated finance subsidiary, PepsiCo Singapore Financing I Pte. Ltd., which has no assets, operations, revenues or cash flows other than those related to the issuance, administration and repayment of the notes and any other notes that may be issued in the future. The notes are fully and unconditionally guaranteed by PepsiCo, Inc. on a senior unsecured basis and may be assumed at any time by PepsiCo, Inc. as the primary and sole obligor. The net proceeds from the issuances of the above notes were used for general corporate purposes, including the repayment of commercial paper. In the 36 weeks ended September 7, 2024 , $1.3 billion of U.S. dollar-denominated senior notes, €1.0 billion of euro-denominated senior notes and C$0.8 billion of Canadian dollar-denominated senior notes matured and were paid. As of September 7, 2024, we had $2.0 billion of commercial paper outstanding, excluding discounts. In the 36 weeks ended September 7, 2024, we entered into a new five-year unsecured revolving credit agreement (Five-Year Credit Agreement), which expires on May 24, 2029. The Five-Year Credit Agreement enables us and our borrowing subsidiaries to borrow up to $5.0 billion in U.S. dollars and/or euros, including a $0.75 billion swing line subfacility for euro-denominated borrowings permitted to be borrowed on a same-day basis, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $5.75 billion (or the equivalent amount in euros). Additionally, we may, up to two times during the term of the 2024 Five-Year Credit Agreement, request renewal of the agreement for an additional one-year period. The Five-Year Credit Agreement replaced our $4.2 billion five-year credit agreement, dated as of May 26, 2023. Also in the 36 weeks ended September 7, 2024, we entered into a new 364-day unsecured revolving credit agreement (364-Day Credit Agreement), which expires on May 23, 2025. The 364-Day Credit Agreement enables us and our borrowing subsidiaries to borrow up to $5.0 billion in U.S. dollars and/or euros, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $5.75 billion (or the equivalent amount in euros). We may request renewal of this facility for an additional 364-day period or convert any amounts outstanding into a term loan for a period of up to one year, which term loan would mature no later than the anniversary of the then effective termination date. The 364-Day Credit Agreement replaced our $4.2 billion 364-day credit agreement, dated as of May 26, 2023. Funds borrowed under the Five-Year Credit Agreement and the 364-Day Credit Agreement may be used for general corporate purposes. Subject to certain conditions, we may borrow, prepay and reborrow amounts under these agreements. As of September 7, 2024, there were no outstanding borrowings under the Five-Year Credit Agreement or the 364-Day Credit Agreement.

Financial Instruments

Financial Instruments	8 Months Ended
	Sep. 07, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments	Financial Instruments We are exposed to market risks arising from adverse changes in: • commodity prices, affecting the cost of our raw materials and energy; • foreign exchange rates and currency restrictions; and • interest rates. In 2024, we included the use of cross-currency contracts to hedge the foreign currency risk associated with our net investment in foreign operations in our hedging strategies. In the 12 and 36 weeks ended September 7, 2024, we entered into cross-currency interest rate swaps with a total notional amount of $500 million for Chinese renminbi and maturity dates ranging from November 2025 to November 2029. The cross-currency interest rate swaps are designated as net investment hedges to hedge the net assets of certain foreign operations with Chinese renminbi functional currency. We use the spot method to assess hedge effectiveness for our net investment hedges. Changes in the fair value of the cross-currency interest rate swaps attributable to spot exchange rate changes are recorded in accumulated other comprehensive loss within common shareholders’ equity as currency translation adjustment to offset changes in the value of the net investments being hedged. These amounts will remain in accumulated other comprehensive loss until the hedged foreign operation is either sold or substantially liquidated. Excluded components in the form of interest accruals are recorded in net interest expense and other. Cash flows associated with the settlement of derivative instruments designated as net investment hedges of foreign operations are classified within investing activities. There have been no other material changes during the 36 weeks ended September 7, 2024 with respect to our risk management policies or strategies and valuation techniques used in measuring the fair value of the financial assets or liabilities disclosed in Note 9 to our consolidated financial statements in our 2023 Form 10-K. Certain of our agreements with our counterparties require us to post full collateral on derivative instruments in a net liability position if our credit rating is at A2 (Moody’s Investors Service, Inc.) or A (S&P Global Ratings) and we have been placed on credit watch for possible downgrade or if our credit rating falls below either of these levels. The fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of September 7, 2024 was $171 million. We have posted no collateral under these contracts and no credit-risk-related contingent features were triggered as of September 7, 2024. The notional amounts of our financial instruments used to hedge the above risks as of September 7, 2024 and December 30, 2023 are as follows: Notional Amounts (a) 9/7/2024 12/30/2023 Commodity contracts $ 1.4 $ 1.7 Foreign exchange contracts $ 3.1 $ 3.8 Cross-currency contracts $ 1.2 $ 1.3 Non-derivative debt instruments $ 3.1 $ 3.0 (a) In billions. As of September 7, 2024 and December 30, 2023 approximately 9% of total debt was subject to variable rates. Debt Securities Held-to-Maturity As of September 7, 2024, we had $46 million of investments in foreign government treasury held-to-maturity debt securities recorded in cash and cash equivalents. As of December 30, 2023, we had $309 million of investments in commercial paper held-to-maturity debt securities recorded in cash and cash equivalents. Held-to-maturity debt securities are recorded at amortized cost, which approximates fair value, and realized gains or losses are reported in earnings. As of September 7, 2024 and December 30, 2023, gross unrecognized gains and losses and the allowance for expected credit losses were not material. Available-for-Sale There were no material impairment charges related to investments in available-for-sale debt securities in both the 36 weeks ended September 7, 2024 and September 9, 2023. There were unrealized gains of $347 million as of September 7, 2024 and no unrealized gains or losses as of September 9, 2023 related to investments in available-for-sale debt securities. Related to our Level 3 (significant unobservable inputs) investment in Celsius Holdings, Inc. (Celsius), we recorded an unrealized loss of $453 million and $265 million in other comprehensive income during the 12 and 36 weeks ended September 7, 2024, respectively. Additionally, we recorded a decrease in the investment of $7 million and $14 million due to cash dividends received during the 12 and 36 weeks ended September 7, 2024, respectively. There were no Level 3 investments in available-for-sale debt securities during the 36 weeks ended September 9, 2023. TBG Investment In the 36 weeks ended September 9, 2023, we recorded our proportionate 39% share of TBG’s impairment of indefinite-lived intangible assets, and recorded an other-than-temporary impairment of our equity method investment, both of which resulted in pre-tax impairment charges of $113 million ($86 million after-tax or $0.06 per share), recorded in selling, general and administrative expenses in our PBNA division. We estimated the fair value of our ownership in TBG using discounted cash flows and an option pricing model related to our liquidation preference in TBG, which we categorized as Level 3 in the fair value hierarchy. There were no impairment charges recorded in the 36 weeks ended September 7, 2024. Recurring Fair Value Measurements The fair values of our financial assets and liabilities as of September 7, 2024 and December 30, 2023 are categorized as follows: 9/7/2024 12/30/2023 Fair Value Hierarchy Levels (a) Assets (a) Liabilities (a) Assets (a) Liabilities (a) Available-for-sale debt securities (b) 2,3 $ 1,061 $ — $ 1,334 $ — Index funds (c) 1 $ 318 $ — $ 292 $ — Prepaid forward contracts (d) 2 $ 17 $ — $ 13 $ — Deferred compensation (e) 2 $ — $ 490 $ — $ 477 Derivatives designated as cash flow hedging instruments: Foreign exchange contracts (f) 2 $ 35 $ 11 $ 3 $ 31 Cross-currency contracts (f) 2 — 138 5 135 Commodity contracts (g) 2 4 16 10 24 $ 39 $ 165 $ 18 $ 190 Derivatives designated as net investment hedging instruments: Cross-currency contracts (f) 2 $ — $ 13 $ — $ — $ — $ 13 $ — $ — Derivatives not designated as hedging instruments: Foreign exchange contracts (f) 2 $ 17 $ 14 $ 33 $ 38 Commodity contracts (g) 2 3 9 5 13 $ 20 $ 23 $ 38 $ 51 Total derivatives at fair value (h) $ 59 $ 201 $ 56 $ 241 Total $ 1,455 $ 691 $ 1,695 $ 718 (a) Fair value hierarchy levels are categorized consistently by Level 1 (quoted prices in active markets for identical assets), Level 2 (significant other observable inputs) and Level 3 in both years. Unless otherwise noted, financial assets are classified on our balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our balance sheet within accounts payable and other current liabilities and other liabilities. (b) Includes Level 2 assets of $184 million and Level 3 assets of $877 million as of September 7, 2024, and Level 2 assets of $178 million and Level 3 assets of $1,156 million as of December 30, 2023 . As of September 7, 2024 and December 30, 2023, $1,061 million and $1,334 million were classified as other assets, respectively. The fair values of our Level 2 investments approximate the transaction price and any accrued returns, as well as the amortized cost. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80% probability that a certain market-based condition will be met and an average estimated discount rate of 5.8% and 8.1% as of September 7, 2024 a nd December 30, 2023, respectively, based on Celsius’ estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. (c) Based on the price of index funds. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability. (d) Based primarily on the price of our common stock. (e) Based on the fair value of investments corresponding to employees’ investment elections. (f) Based on recently reported market transactions of spot and forward rates. (g) Primarily based on recently reported market transactions of swap arrangements. (h) Derivative assets and liabilities are presented on a gross basis on our balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on our balance sheet as of September 7, 2024 and December 30, 2023 were not material. Collateral received or posted against our asset or liability positions was not material. Exchange-traded commodity futures are cash-settled on a daily basis and, therefore, not included in the table. The carrying amounts of our cash and cash equivalents and short-term investments recorded at amortized cost approximate fair value (classified as Level 2 in the fair value hierarchy) due to their short-term maturity. The fair value of our debt obligations as of September 7, 2024 and December 30, 2023 was $42 billion and $41 billion, respectively, based upon prices of identical or similar instruments in the marketplace, which are considered Level 2 inputs. Losses/(gains) on our cash flow hedges are categorized as follows: 12 Weeks Ended Losses/(Gains) Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement (a) 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Foreign exchange contracts $ (33) $ 15 $ (3) $ 26 Cross-currency contracts (15) 23 (21) 31 Commodity contracts 75 65 34 24 Total $ 27 $ 103 $ 10 $ 81 36 Weeks Ended Losses/(Gains) Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement (a) 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Foreign exchange contracts $ (48) $ 74 $ 15 $ 41 Cross-currency contracts 19 (3) 14 4 Commodity contracts 103 115 85 61 Total $ 74 $ 186 $ 114 $ 106 (a) Foreign exchange derivative losses/(gains) are included in net revenue and cost of sales. Cross-currency interest rate swap derivative losses/(gains) are included in selling, general and administrative expenses. Commodity derivative losses/(gains) are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. See Note 11 for further information. Losses/(gains) on our net investment hedges are categorized as follows: 12 Weeks Ended Losses/(Gains) Losses/(Gains) Recognized in Net Income (a) 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Non-derivative debt instruments $ 114 $ (68) $ — $ — Cross-currency contracts 13 — (2) — Total $ 127 $ (68) $ (2) $ — 36 Weeks Ended Losses/(Gains) Losses/(Gains) Recognized in Net Income (a) 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Non-derivative debt instruments $ 45 $ 40 $ — $ — Cross-currency contracts 13 — (2) — Total $ 58 $ 40 $ (2) $ — (a) Amount excluded from the assessment of effectiveness recognized in earnings associated with cross-currency interest rate swaps. Based on current market conditions, we expect to reclassify net losses of $62 million related to our cash flow hedges from accumulated other comprehensive loss within common shareholders’ equity into net income during the next 12 months. Losses/(gains) recognized in the income statement related to our non-designated hedges are categorized as follows: 12 Weeks Ended 9/7/2024 9/9/2023 Cost of sales Selling, general and administrative expenses Total Cost of sales Selling, general and administrative expenses Total Foreign exchange contracts $ 1 $ (8) $ (7) $ — $ (7) $ (7) Commodity contracts 24 36 60 (9) (65) (74) Total $ 25 $ 28 $ 53 $ (9) $ (72) $ (81) 36 Weeks Ended 9/7/2024 9/9/2023 Cost of sales Selling, general and administrative expenses Total Cost of sales Selling, general and administrative expenses Total Foreign exchange contracts $ 1 $ 34 $ 35 $ (1) $ 32 $ 31 Commodity contracts 9 16 25 27 (12) 15 Total $ 10 $ 50 $ 60 $ 26 $ 20 $ 46

Net Income Attributable to Peps

Net Income Attributable to PepsiCo per Common Share	8 Months Ended
	Sep. 07, 2024
Earnings Per Share [Abstract]
Net Income Attributable to PepsiCo per Common Share	Net Income Attributable to PepsiCo per Common Share The computations of basic and diluted net income attributable to PepsiCo per common share are as follows: 12 Weeks Ended 9/7/2024 9/9/2023 Income Shares (a) Income Shares (a) Basic net income attributable to PepsiCo per common share $ 2.13 $ 2.25 Net income available for PepsiCo common shareholders $ 2,930 1,373 $ 3,092 1,376 Dilutive securities: Stock options, RSUs, PSUs and other (b) — 5 — 7 Diluted $ 2,930 1,378 $ 3,092 1,383 Diluted net income attributable to PepsiCo per common share $ 2.13 $ 2.24 36 Weeks Ended 9/7/2024 9/9/2023 Income Shares (a) Income Shares (a) Basic net income attributable to PepsiCo per common share $ 5.86 $ 5.64 Net income available for PepsiCo common shareholders $ 8,055 1,374 $ 7,772 1,377 Dilutive securities: Stock options, RSUs, PSUs and other (b) — 5 — 7 Diluted $ 8,055 1,379 $ 7,772 1,384 Diluted net income attributable to PepsiCo per common share $ 5.84 $ 5.62 (a) Weighted-average common shares outstanding (in millions). (b) The dilutive effect of these securities is calculated using the treasury stock method. The weighted-average amount of antidilutive securities excluded from the calculation of diluted earnings per common share was 4 million for the 12 and 36 weeks ended September 7, 2024, and was immaterial for the 12 and 36 weeks ended September 9, 2023.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss Attributable to PepsiCo	8 Months Ended
	Sep. 07, 2024
Equity [Abstract]
Accumulated Other Comprehensive Loss Attributable to PepsiCo	Accumulated Other Comprehensive Loss Attributable to PepsiCo The changes in the balances of each component of accumulated other comprehensive loss attributable to PepsiCo are as follows: Currency Translation Adjustment Cash Flow Hedges Pension and Retiree Medical Available-for-Sale Debt Securities and Other (a) Accumulated Other Comprehensive Loss Attributable to PepsiCo Balance as of December 30, 2023 (b) $ (13,255) $ (31) $ (2,719) $ 471 $ (15,534) Other comprehensive (loss)/income before reclassifications (c) (168) (47) 4 685 474 Amounts reclassified from accumulated other comprehensive loss — 51 9 — 60 Net other comprehensive (loss)/income (168) 4 13 685 534 Tax amounts (14) (1) (2) (162) (179) Balance as of March 23, 2024 (b) (13,437) (28) (2,708) 994 (15,179) Other comprehensive (loss)/income before reclassifications (d) (295) 3 (1) (511) (804) Amounts reclassified from accumulated other comprehensive loss — 53 12 — 65 Net other comprehensive (loss)/income (295) 56 11 (511) (739) Tax amounts 28 (14) (2) 120 132 Balance as of June 15, 2024 (b) (13,704) 14 (2,699) 603 (15,786) Other comprehensive (loss)/income before reclassifications (e) (544) (34) — (460) (1,038) Amounts reclassified from accumulated other comprehensive loss — 7 25 — 32 Net other comprehensive (loss)/income (544) (27) 25 (460) (1,006) Tax amounts 32 3 (4) 109 140 Balance as of September 7, 2024 (b) $ (14,216) $ (10) $ (2,678) $ 252 $ (16,652) (a) The movements during the quarters primarily represent fair value changes in available-for-sale debt securities, including our investment in Celsius convertible preferred stock. See Note 9 for further information. (b) Pension and retiree medical amounts are net of taxes of $1,282 million as of December 30, 2023, $1,280 million as of March 23, 2024 , $1,278 million as of June 15, 2024 and $1,274 million as of September 7, 2024. (c) Currency translation adjustment primarily reflects depreciation of the South African rand, Canadian dollar and Russian ruble. (d) Currency translation adjustment primarily reflects depreciation of the Egyptian pound. (e) Currency translation adjustment primarily reflects depreciation of the Mexican peso. Currency Translation Adjustment Cash Flow Hedges Pension and Retiree Medical Available-for-Sale Debt Securities and Other Accumulated Other Comprehensive Loss Attributable Balance as of December 31, 2022 (a) $ (12,948) $ 1 $ (2,361) $ 6 $ (15,302) Other comprehensive (loss) before reclassifications (b) (350) (92) (9) (1) (452) Amounts reclassified from accumulated other comprehensive loss (c) 108 13 5 — 126 Net other comprehensive (loss) (242) (79) (4) (1) (326) Tax amounts 7 20 — — 27 Balance as of March 25, 2023 (a) (13,183) (58) (2,365) 5 (15,601) Other comprehensive (loss)/income before reclassifications (d) (215) 19 (14) 1 (209) Amounts reclassified from accumulated other comprehensive loss — 12 5 — 17 Net other comprehensive (loss)/income (215) 31 (9) 1 (192) Tax amounts 17 (7) 3 — 13 Balance as of June 17, 2023 (a) (13,381) (34) (2,371) 6 (15,780) Other comprehensive income/(loss) before reclassifications (e) 19 (96) (15) 3 (89) Amounts reclassified from accumulated other comprehensive loss — 81 5 — 86 Net other comprehensive income/(loss) 19 (15) (10) 3 (3) Tax amounts (17) 4 2 — (11) Balance as of September 9, 2023 (a) $ (13,379) $ (45) $ (2,379) $ 9 $ (15,794) (a) Pension and retiree medical amounts are net of taxes of $1,184 million as of both December 31, 2022 and March 25, 2023, $1,187 million as of June 17, 2023 and $1,189 million as of September 9, 2023. (b) Currency translation adjustment primarily reflects depreciation of the Egyptian pound and Russian ruble. (c) Release of currency translation adjustment is in relation to the sale of a non-strategic brand and an investment within our AMESA division. (d) Currency translation adjustment primarily reflects depreciation of the Russian ruble. (e) Currency translation adjustment primarily reflects appreciation of the euro, Mexican peso and South African rand, partially offset by the depreciation of the Russian ruble. The reclassifications from accumulated other comprehensive loss to the income statement are summarized as follows: 12 Weeks Ended 36 Weeks Ended 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Affected Line Item in the Income Statement Currency translation: Divestitures $ — $ — $ — $ 108 Selling, general and administrative expenses Cash flow hedges: Foreign exchange contracts $ (1) $ — $ (1) $ (3) Net revenue Foreign exchange contracts (2) 26 16 44 Cost of sales Cross currency contracts and interest rate derivatives (24) 31 11 4 Selling, general and administrative expenses Commodity contracts 34 23 85 61 Cost of sales Commodity contracts — 1 — — Selling, general and administrative expenses Net losses before tax 7 81 111 106 Tax amounts (1) (20) (28) (27) Net losses after tax $ 6 $ 61 $ 83 $ 79 Pension and retiree medical items: Amortization of prior service credits $ (7) $ (8) $ (21) $ (23) Other pension and retiree medical benefits income Amortization of net losses 17 13 50 38 Other pension and retiree medical benefits income Settlement losses 15 — 17 — Other pension and retiree medical benefits income Net losses before tax 25 5 46 15 Tax amounts (5) (1) (9) (3) Net losses after tax $ 20 $ 4 $ 37 $ 12 Total net losses reclassified, net of tax $ 26 $ 65 $ 120 $ 199

Supply Chain Financing

Supply Chain Financing	3 Months Ended
	Sep. 07, 2024
Text Block [Abstract]
Supplier Finance Program	Supply Chain Financing Arrangements We maintain voluntary supply chain finance agreements with several participating global financial institutions. Under these agreements, our suppliers, at their sole discretion, may elect to sell their accounts receivable with PepsiCo to these participating global financial institutions. As of September 7, 2024 and December 30, 2023, $1.6 billion and $1.7 billion, respectively, of our accounts payable are to suppliers participating in these financing arrangements. For further information on the key terms of these supply chain financing programs, see Note 14 to our consolidated financial statements in our 2023 Form 10-K.

Subsequent Events

Subsequent Events	8 Months Ended
	Sep. 07, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Event On October 1, 2024, we entered into a definitive agreement to acquire all of the outstanding shares of Garza Food Ventures LLC, doing business as Siete Foods, a Mexican-American foods business, for approximately $1.2 billion in cash. The purchase price will be adjusted for net working capital and net debt amounts as of the acquisition date. The transaction is subject to certain regulatory approvals and other customary closing conditions. Closing is expected in the first half of 2025.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Pay vs Performance Disclosure
Net Income (Loss) Attributable to Parent	$ 2,930	$ 3,092	$ 8,055	$ 7,772

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 07, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Basis of Presentation and Our_2

Basis of Presentation and Our Divisions (Policies)	8 Months Ended
	Sep. 07, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Fiscal Period, Policy	While our financial results in the United States and Canada (North America) are reported on a 12-week basis, all of our international operations are reported on a monthly calendar basis for which the months of June, July and August are reflected in our results for the 12 weeks ended September 7, 2024 and September 9, 2023, and the months of January through August are reflected in our results for the 36 weeks ended September 7, 2024 and September 9, 2023.

Accounting Policies (Policies)

Accounting Policies (Policies)	8 Months Ended
	Sep. 07, 2024
Accounting Policies [Abstract]
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Adopted In September 2022, the Financial Accounting Standards Board (FASB) issued guidance to enhance the transparency of supplier finance programs to allow financial statement users to understand the effect on working capital, liquidity and cash flows. The new guidance requires disclosure of key terms of the program, including a description of the payment terms, payment timing and assets pledged as security or other forms of guarantees provided to the finance provider or intermediary. Other requirements include the disclosure of the amount that remains unpaid as of the end of the reporting period, a description of where these obligations are presented in the balance sheet and a rollforward of the obligation during the annual period. We adopted the guidance in the first quarter of 2023, except for the rollforward, which is effective for the current fiscal year 2024. We will adopt the rollforward guidance when it becomes effective in our 2024 annual reporting, on a prospective basis. See Note 12 for disclosures currently required under this guidance. Not Yet Adopted In December 2023, the FASB issued guidance to enhance transparency of income tax disclosures. On an annual basis, the new guidance requires a public entity to disclose: (1) specific categories in the rate reconciliation, (2) additional information for reconciling items that are equal to or greater than 5% of the amount computed by multiplying income (or loss) from continuing operations before income tax expense (or benefit) by the applicable statutory income tax rate, (3) income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes, with foreign taxes disaggregated by individual jurisdictions in which income taxes paid is equal to or greater than 5% of total income taxes paid, (4) income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and (5) income tax expense (or benefit) from continuing operations disaggregated between federal (national), state and foreign. The guidance is effective for fiscal year 2025 annual reporting, with early adoption permitted, to be applied on a prospective basis, with retrospective application permitted. We will adopt the guidance when it becomes effective, in our 2025 annual reporting, on a prospective basis. In November 2023, the FASB issued guidance to enhance disclosure of expenses of a public entity’s reportable segments. The new guidance requires a public entity to disclose: (1) on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker (CODM) and included within each reported measure of segment profit or loss, (2) on an annual and interim basis, an amount for other segment items (the difference between segment revenue less the significant expenses disclosed under the significant expense principle and each reported measure of segment profit or loss), including a description of its composition, (3) on an annual and interim basis, information about a reportable segment’s profit or loss and assets previously required to be disclosed only on an annual basis, and (4) the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and how to allocate resources. The new guidance also clarifies that if the CODM uses more than one measure of a segment’s profit or loss, one or more of those measures may be reported and requires that a public entity that has a single reportable segment provide all the disclosures required by the amendments in this update and all existing segment disclosures. The guidance is effective for the current fiscal year 2024 annual reporting, and in the first quarter of 2025 for interim period reporting, with early adoption permitted. Upon adoption, this guidance should be applied retrospectively to all prior periods presented. We will adopt the guidance when it becomes effective in our 2024 annual reporting.

Basis of Presentation and Our_3

Basis of Presentation and Our Divisions (Tables)	8 Months Ended
	Sep. 07, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Segment Reporting Information By Net Revenue	Net revenue of each division is as follows: 12 Weeks Ended 36 Weeks Ended 9/7/2024 9/9/2023 9/7/2024 9/9/2023 FLNA $ 5,888 $ 5,954 $ 17,438 $ 17,441 QFNA 648 747 1,802 2,208 PBNA 7,175 7,161 19,860 19,714 LatAm 2,915 3,055 8,027 7,688 Europe 3,946 3,704 9,397 9,018 AMESA 1,552 1,615 4,184 4,202 APAC 1,195 1,217 3,362 3,350 Total $ 23,319 $ 23,453 $ 64,070 $ 63,621
Summary of Segment Reporting Information by Percentage of Disaggregated Net Revenue	Our primary performance obligation is the distribution and sales of beverage and convenient food products to our customers. The following tables reflect the percentage of net revenue generated between our beverage business and our convenient food business for each of our international divisions, as well as our consolidated net revenue: 12 Weeks Ended 9/7/2024 9/9/2023 Beverages (a) Convenient Foods Beverages (a) Convenient Foods LatAm 10 % 90 % 10 % 90 % Europe 51 % 49 % 50 % 50 % AMESA 31 % 69 % 31 % 69 % APAC 26 % 74 % 27 % 73 % PepsiCo 44 % 56 % 43 % 57 % 36 Weeks Ended 9/7/2024 9/9/2023 Beverages (a) Convenient Foods Beverages (a) Convenient Foods LatAm 10 % 90 % 9 % 91 % Europe 48 % 52 % 49 % 51 % AMESA 32 % 68 % 31 % 69 % APAC 23 % 77 % 23 % 77 % PepsiCo 43 % 57 % 42 % 58 % (a) Beverage revenue from company-owned bottlers, which primarily includes our consolidated bottling operations in our PBNA and Europe divisions, was 37% and 36% of our consolidated net revenue in the 12 and 36 weeks ended September 7, 2024, respectively, and 36% of our consolidated net revenue in the 12 and 36 weeks ended September 9, 2023. Generally, our finished goods beverage operations produce higher net revenue but lower operating margin as compared to concentrate sold to authorized bottling partners for the manufacture of finished goods beverages.
Summary of Segment Reporting Information by Operating Profit	Operating profit of each division is as follows: 12 Weeks Ended 36 Weeks Ended 9/7/2024 9/9/2023 9/7/2024 9/9/2023 FLNA $ 1,523 $ 1,669 $ 4,669 $ 4,915 QFNA (a) 97 135 133 452 PBNA (b) 914 970 2,411 2,176 LatAm 595 593 1,717 1,549 Europe 728 659 1,550 1,206 AMESA 197 238 590 656 APAC 262 239 718 689 Total divisions 4,316 4,503 11,788 11,643 Corporate unallocated expenses (c) (444) (488) (1,151) (1,340) Total $ 3,872 $ 4,015 $ 10,637 $ 10,303 (a) In the 36 weeks ended September 7, 2024, we recorded a pre-tax charge of $184 million ($141 million after-tax or $0.10 per share) associated with a previously announced voluntary recall of certain bars and cereals in our QFNA division (Quaker Recall) with $174 million recorded in cost of sales related to property, plant and equipment write-offs, employee severance costs and other costs, $7 million recorded in selling, general and administrative expenses and $3 million recorded in other pension and retiree medical benefits income, which is not included in operating profit. (b) In the 36 weeks ended September 9, 2023, we recorded our proportionate 39% share of Tropicana Brands Group’s (TBG) impairment of indefinite-lived intangible assets, and recorded an other-than-temporary impairment of our equity method investment, both of which resulted in pre-tax impairment charges of $113 million ($86 million after-tax or $0.06 per share), recorded in selling, general and administrative expenses. See Note 9 for further information. (c) In the 36 weeks ended September 7, 2024 and September 9, 2023, we recorded a pre-tax gain of $76 million ($57 million after-tax or $0.04 per share) and $85 million ($65 million after-tax or $0.05 per share), respectively, in selling, general and administrative expenses as a result of the sale of corporate assets.

Restructuring and Impairment _2

Restructuring and Impairment Charges (Tables)	8 Months Ended
	Sep. 07, 2024
2019 Productivity Plan
Restructuring Cost and Reserve [Line Items]
Summary of Productivity Plan Activity	The total plan pre-tax charges are expected to be incurred by division approximately as follows: FLNA QFNA PBNA LatAm Europe AMESA APAC Corporate Expected pre-tax charges 10 % 1 % 30 % 10 % 25 % 5 % 4 % 15 % A summary of our 2019 Productivity Plan charges is as follows: 12 Weeks Ended 36 Weeks Ended 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Cost of sales $ 10 $ 4 $ 16 $ 10 Selling, general and administrative expenses 228 79 377 278 Other pension and retiree medical benefits expense/(income) (a) 7 — 22 (1) Total restructuring and impairment charges $ 245 $ 83 $ 415 $ 287 After-tax amount $ 195 $ 67 $ 325 $ 228 Impact on net income attributable to PepsiCo per common share $ (0.14) $ (0.05) $ (0.24) $ (0.16) 12 Weeks Ended 36 Weeks Ended Plan-to-Date 9/7/2024 9/9/2023 9/7/2024 9/9/2023 through 9/7/2024 FLNA $ 8 $ 6 $ 43 $ 19 $ 295 QFNA — — 4 — 23 PBNA 128 8 143 18 410 LatAm 11 8 32 19 232 Europe 46 44 83 185 649 AMESA 4 5 7 10 104 APAC 2 2 6 7 91 Corporate 39 10 75 30 392 238 83 393 288 2,196 Other pension and retiree medical benefits expense/(income) (a) 7 — 22 (1) 119 Total $ 245 $ 83 $ 415 $ 287 $ 2,315 (a) Income amount represents adjustments for changes in estimates of previously recorded amounts. 12 Weeks Ended 36 Weeks Ended Plan-to-Date 9/7/2024 9/9/2023 9/7/2024 9/9/2023 through 9/7/2024 Severance and other employee costs $ 151 $ 39 $ 233 $ 181 $ 1,283 Asset impairments 30 1 34 1 226 Other costs 64 43 148 105 806 Total $ 245 $ 83 $ 415 $ 287 $ 2,315 A summary of our 2019 Productivity Plan activity for the 36 weeks ended September 7, 2024 is as follows: Severance and Other Employee Costs Asset Other Costs Total Liability as of December 30, 2023 $ 188 $ — $ 9 $ 197 2024 restructuring charges 233 34 148 415 Cash payments (131) — (153) (284) Non-cash charges and translation (17) (34) 22 (29) Liability as of September 7, 2024 $ 273 $ — $ 26 $ 299

Intangible Assets (Tables)

Intangible Assets (Tables)	8 Months Ended
	Sep. 07, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	A summary of our amortizable intangible assets is as follows: 9/7/2024 12/30/2023 Gross Accumulated Amortization Net Gross Accumulated Amortization Net Acquired franchise rights $ 836 $ (224) $ 612 $ 840 $ (214) $ 626 Customer relationships 561 (284) 277 560 (265) 295 Brands 1,087 (996) 91 1,093 (989) 104 Other identifiable intangibles 428 (276) 152 449 (275) 174 Total $ 2,912 $ (1,780) $ 1,132 $ 2,942 $ (1,743) $ 1,199
Schedule Of Change In Book Value Of Indefinite-Lived Intangible Assets	The change in the book value of indefinite-lived intangible assets is as follows: Balance 12/30/2023 Translation Balance 9/7/2024 FLNA Goodwill $ 453 $ (2) $ 451 Brands 251 — 251 Total 704 (2) 702 QFNA Goodwill 189 — 189 Total 189 — 189 PBNA Goodwill 11,961 (8) 11,953 Reacquired franchise rights 7,114 (14) 7,100 Acquired franchise rights 1,737 (3) 1,734 Brands 2,508 — 2,508 Total 23,320 (25) 23,295 LatAm Goodwill 460 (29) 431 Brands 82 (6) 76 Total 542 (35) 507 Europe Goodwill 3,166 3 3,169 Reacquired franchise rights 419 2 421 Acquired franchise rights 154 (10) 144 Brands 1,124 20 1,144 Total 4,863 15 4,878 AMESA Goodwill 991 17 1,008 Brands 137 6 143 Total 1,128 23 1,151 APAC Goodwill 508 — 508 Brands 204 — 204 Total 712 — 712 Total goodwill 17,728 (19) 17,709 Total reacquired franchise rights 7,533 (12) 7,521 Total acquired franchise rights 1,891 (13) 1,878 Total brands 4,306 20 4,326 Total $ 31,458 $ (24) $ 31,434

Share-Based Compensation (Table

Share-Based Compensation (Tables)	8 Months Ended
	Sep. 07, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan	The following table summarizes our total share-based compensation expense, which is primarily recorded in selling, general and administrative expenses: 12 Weeks Ended 36 Weeks Ended 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Share-based compensation expense – equity awards $ 77 $ 88 $ 260 $ 267 Share-based compensation expense – liability awards 4 7 14 19 Restructuring charges (1) — (5) — Total $ 80 $ 95 $ 269 $ 286
Schedule of Share-based Payment Award, PepsiCo, Inc. Long-Term Incentive Plan	The following table summarizes share-based awards granted under the terms of the PepsiCo, Inc. Long-Term Incentive Plan: 36 Weeks Ended 9/7/2024 9/9/2023 Granted (a) Weighted-Average Grant Price Granted (a) Weighted-Average Grant Price Stock options 2.0 $ 164.28 2.1 $ 171.83 RSUs and PSUs 2.3 $ 164.25 2.1 $ 171.11 (a)
Schedule Of Weighted-Average Black-Scholes Fair Value Assumptions	Our weighted-average Black-Scholes fair value assumptions are as follows: 36 Weeks Ended 9/7/2024 9/9/2023 Expected life 7 years 7 years Risk-free interest rate 4.2 % 4.2 % Expected volatility 16 % 16 % Expected dividend yield 2.9 % 2.7 %

Pension and Retiree Medical B_2

Pension and Retiree Medical Benefits - Periodic Benefit Cost (Tables)	8 Months Ended
	Sep. 07, 2024
Retirement Benefits [Abstract]
Schedule of Defined Benefit Plans Disclosures	The components of net periodic benefit cost/(income) for pension and retiree medical plans are as follows: 12 Weeks Ended Pension Retiree Medical U.S. International 9/7/2024 9/9/2023 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Service cost $ 80 $ 76 $ 11 $ 10 $ 7 $ 7 Other pension and retiree medical benefits income: Interest cost 135 137 36 34 7 7 Expected return on plan assets (201) (197) (50) (45) (3) (3) Amortization of prior service credits (6) (6) — (1) (1) (1) Amortization of net losses/(gains) 17 16 6 3 (6) (6) Settlement losses 8 — 7 — — — Special termination benefits 8 — — — 2 — Total other pension and retiree medical benefits income (39) (50) (1) (9) (1) (3) Total $ 41 $ 26 $ 10 $ 1 $ 6 $ 4 36 Weeks Ended Pension Retiree Medical U.S. International 9/7/2024 9/9/2023 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Service cost $ 240 $ 227 $ 32 $ 28 $ 22 $ 20 Other pension and retiree medical benefits income: Interest cost 405 411 99 93 22 24 Expected return on plan assets (604) (590) (139) (126) (9) (9) Amortization of prior service credits (17) (18) (1) (1) (3) (4) Amortization of net losses/(gains) 53 48 15 8 (18) (18) Settlement losses 8 — 9 — — — Special termination benefits 23 (1) — — 2 — Total other pension and retiree medical benefits income (132) (150) (17) (26) (6) (7) Total $ 108 $ 77 $ 15 $ 2 $ 16 $ 13

Debt Obligations (Tables)

Debt Obligations (Tables)	8 Months Ended
	Sep. 07, 2024
Debt Disclosure [Abstract]
Schedule of Debt Issuances	In the 36 weeks ended September 7, 2024, we issued the following notes: Interest Rate Maturity Date Principal Amount (a) Floating rate February 2027 $ 300 (b) 4.650 % February 2027 $ 550 (b) 4.550 % February 2029 $ 450 (b) 4.700 % February 2034 $ 450 (b) 4.500 % July 2029 $ 850 4.800 % July 2034 $ 650 5.250 % July 2054 $ 750 (a) Excludes debt issuance costs, discounts and premiums. (b) Issued through our wholly-owned consolidated finance subsidiary, PepsiCo Singapore Financing I Pte. Ltd., which has no assets, operations, revenues or cash flows other than those related to the issuance, administration and repayment of the notes and any other notes that may be issued in the future. The notes are fully and unconditionally guaranteed by PepsiCo, Inc. on a senior unsecured basis and may be assumed at any time by PepsiCo, Inc. as the primary and sole obligor.

Financial Instruments (Tables)

Financial Instruments (Tables)	8 Months Ended
	Sep. 07, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts of Financial Instruments	The notional amounts of our financial instruments used to hedge the above risks as of September 7, 2024 and December 30, 2023 are as follows: Notional Amounts (a) 9/7/2024 12/30/2023 Commodity contracts $ 1.4 $ 1.7 Foreign exchange contracts $ 3.1 $ 3.8 Cross-currency contracts $ 1.2 $ 1.3 Non-derivative debt instruments $ 3.1 $ 3.0 (a) In billions.
Summary of Fair Values of Financial Assets and Liabilities	The fair values of our financial assets and liabilities as of September 7, 2024 and December 30, 2023 are categorized as follows: 9/7/2024 12/30/2023 Fair Value Hierarchy Levels (a) Assets (a) Liabilities (a) Assets (a) Liabilities (a) Available-for-sale debt securities (b) 2,3 $ 1,061 $ — $ 1,334 $ — Index funds (c) 1 $ 318 $ — $ 292 $ — Prepaid forward contracts (d) 2 $ 17 $ — $ 13 $ — Deferred compensation (e) 2 $ — $ 490 $ — $ 477 Derivatives designated as cash flow hedging instruments: Foreign exchange contracts (f) 2 $ 35 $ 11 $ 3 $ 31 Cross-currency contracts (f) 2 — 138 5 135 Commodity contracts (g) 2 4 16 10 24 $ 39 $ 165 $ 18 $ 190 Derivatives designated as net investment hedging instruments: Cross-currency contracts (f) 2 $ — $ 13 $ — $ — $ — $ 13 $ — $ — Derivatives not designated as hedging instruments: Foreign exchange contracts (f) 2 $ 17 $ 14 $ 33 $ 38 Commodity contracts (g) 2 3 9 5 13 $ 20 $ 23 $ 38 $ 51 Total derivatives at fair value (h) $ 59 $ 201 $ 56 $ 241 Total $ 1,455 $ 691 $ 1,695 $ 718 (a) Fair value hierarchy levels are categorized consistently by Level 1 (quoted prices in active markets for identical assets), Level 2 (significant other observable inputs) and Level 3 in both years. Unless otherwise noted, financial assets are classified on our balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our balance sheet within accounts payable and other current liabilities and other liabilities. (b) Includes Level 2 assets of $184 million and Level 3 assets of $877 million as of September 7, 2024, and Level 2 assets of $178 million and Level 3 assets of $1,156 million as of December 30, 2023 . As of September 7, 2024 and December 30, 2023, $1,061 million and $1,334 million were classified as other assets, respectively. The fair values of our Level 2 investments approximate the transaction price and any accrued returns, as well as the amortized cost. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80% probability that a certain market-based condition will be met and an average estimated discount rate of 5.8% and 8.1% as of September 7, 2024 a nd December 30, 2023, respectively, based on Celsius’ estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. (c) Based on the price of index funds. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability. (d) Based primarily on the price of our common stock. (e) Based on the fair value of investments corresponding to employees’ investment elections. (f) Based on recently reported market transactions of spot and forward rates. (g) Primarily based on recently reported market transactions of swap arrangements. (h) Derivative assets and liabilities are presented on a gross basis on our balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on our balance sheet as of September 7, 2024 and December 30, 2023 were not material. Collateral received or posted against our asset or liability positions was not material. Exchange-traded commodity futures are cash-settled on a daily basis and, therefore, not included in the table.
Summary of Losses (Gains) On Derivative Instruments	Losses/(gains) on our cash flow hedges are categorized as follows: 12 Weeks Ended Losses/(Gains) Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement (a) 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Foreign exchange contracts $ (33) $ 15 $ (3) $ 26 Cross-currency contracts (15) 23 (21) 31 Commodity contracts 75 65 34 24 Total $ 27 $ 103 $ 10 $ 81 36 Weeks Ended Losses/(Gains) Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement (a) 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Foreign exchange contracts $ (48) $ 74 $ 15 $ 41 Cross-currency contracts 19 (3) 14 4 Commodity contracts 103 115 85 61 Total $ 74 $ 186 $ 114 $ 106 (a) Foreign exchange derivative losses/(gains) are included in net revenue and cost of sales. Cross-currency interest rate swap derivative losses/(gains) are included in selling, general and administrative expenses. Commodity derivative losses/(gains) are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. See Note 11 for further information. Losses/(gains) recognized in the income statement related to our non-designated hedges are categorized as follows: 12 Weeks Ended 9/7/2024 9/9/2023 Cost of sales Selling, general and administrative expenses Total Cost of sales Selling, general and administrative expenses Total Foreign exchange contracts $ 1 $ (8) $ (7) $ — $ (7) $ (7) Commodity contracts 24 36 60 (9) (65) (74) Total $ 25 $ 28 $ 53 $ (9) $ (72) $ (81) 36 Weeks Ended 9/7/2024 9/9/2023 Cost of sales Selling, general and administrative expenses Total Cost of sales Selling, general and administrative expenses Total Foreign exchange contracts $ 1 $ 34 $ 35 $ (1) $ 32 $ 31 Commodity contracts 9 16 25 27 (12) 15 Total $ 10 $ 50 $ 60 $ 26 $ 20 $ 46

Net Income Attributable to Pe_2

Net Income Attributable to PepsiCo per Common Share (Tables)	8 Months Ended
	Sep. 07, 2024
Earnings Per Share [Abstract]
Schedule of Basic And Diluted Net Income Per Common Share	The computations of basic and diluted net income attributable to PepsiCo per common share are as follows: 12 Weeks Ended 9/7/2024 9/9/2023 Income Shares (a) Income Shares (a) Basic net income attributable to PepsiCo per common share $ 2.13 $ 2.25 Net income available for PepsiCo common shareholders $ 2,930 1,373 $ 3,092 1,376 Dilutive securities: Stock options, RSUs, PSUs and other (b) — 5 — 7 Diluted $ 2,930 1,378 $ 3,092 1,383 Diluted net income attributable to PepsiCo per common share $ 2.13 $ 2.24 36 Weeks Ended 9/7/2024 9/9/2023 Income Shares (a) Income Shares (a) Basic net income attributable to PepsiCo per common share $ 5.86 $ 5.64 Net income available for PepsiCo common shareholders $ 8,055 1,374 $ 7,772 1,377 Dilutive securities: Stock options, RSUs, PSUs and other (b) — 5 — 7 Diluted $ 8,055 1,379 $ 7,772 1,384 Diluted net income attributable to PepsiCo per common share $ 5.84 $ 5.62 (a) Weighted-average common shares outstanding (in millions). (b) The dilutive effect of these securities is calculated using the treasury stock method.

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss Attributable to PepsiCo (Tables)	8 Months Ended
	Sep. 07, 2024
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The changes in the balances of each component of accumulated other comprehensive loss attributable to PepsiCo are as follows: Currency Translation Adjustment Cash Flow Hedges Pension and Retiree Medical Available-for-Sale Debt Securities and Other (a) Accumulated Other Comprehensive Loss Attributable to PepsiCo Balance as of December 30, 2023 (b) $ (13,255) $ (31) $ (2,719) $ 471 $ (15,534) Other comprehensive (loss)/income before reclassifications (c) (168) (47) 4 685 474 Amounts reclassified from accumulated other comprehensive loss — 51 9 — 60 Net other comprehensive (loss)/income (168) 4 13 685 534 Tax amounts (14) (1) (2) (162) (179) Balance as of March 23, 2024 (b) (13,437) (28) (2,708) 994 (15,179) Other comprehensive (loss)/income before reclassifications (d) (295) 3 (1) (511) (804) Amounts reclassified from accumulated other comprehensive loss — 53 12 — 65 Net other comprehensive (loss)/income (295) 56 11 (511) (739) Tax amounts 28 (14) (2) 120 132 Balance as of June 15, 2024 (b) (13,704) 14 (2,699) 603 (15,786) Other comprehensive (loss)/income before reclassifications (e) (544) (34) — (460) (1,038) Amounts reclassified from accumulated other comprehensive loss — 7 25 — 32 Net other comprehensive (loss)/income (544) (27) 25 (460) (1,006) Tax amounts 32 3 (4) 109 140 Balance as of September 7, 2024 (b) $ (14,216) $ (10) $ (2,678) $ 252 $ (16,652) (a) The movements during the quarters primarily represent fair value changes in available-for-sale debt securities, including our investment in Celsius convertible preferred stock. See Note 9 for further information. (b) Pension and retiree medical amounts are net of taxes of $1,282 million as of December 30, 2023, $1,280 million as of March 23, 2024 , $1,278 million as of June 15, 2024 and $1,274 million as of September 7, 2024. (c) Currency translation adjustment primarily reflects depreciation of the South African rand, Canadian dollar and Russian ruble. (d) Currency translation adjustment primarily reflects depreciation of the Egyptian pound. (e) Currency translation adjustment primarily reflects depreciation of the Mexican peso. Currency Translation Adjustment Cash Flow Hedges Pension and Retiree Medical Available-for-Sale Debt Securities and Other Accumulated Other Comprehensive Loss Attributable Balance as of December 31, 2022 (a) $ (12,948) $ 1 $ (2,361) $ 6 $ (15,302) Other comprehensive (loss) before reclassifications (b) (350) (92) (9) (1) (452) Amounts reclassified from accumulated other comprehensive loss (c) 108 13 5 — 126 Net other comprehensive (loss) (242) (79) (4) (1) (326) Tax amounts 7 20 — — 27 Balance as of March 25, 2023 (a) (13,183) (58) (2,365) 5 (15,601) Other comprehensive (loss)/income before reclassifications (d) (215) 19 (14) 1 (209) Amounts reclassified from accumulated other comprehensive loss — 12 5 — 17 Net other comprehensive (loss)/income (215) 31 (9) 1 (192) Tax amounts 17 (7) 3 — 13 Balance as of June 17, 2023 (a) (13,381) (34) (2,371) 6 (15,780) Other comprehensive income/(loss) before reclassifications (e) 19 (96) (15) 3 (89) Amounts reclassified from accumulated other comprehensive loss — 81 5 — 86 Net other comprehensive income/(loss) 19 (15) (10) 3 (3) Tax amounts (17) 4 2 — (11) Balance as of September 9, 2023 (a) $ (13,379) $ (45) $ (2,379) $ 9 $ (15,794) (a) Pension and retiree medical amounts are net of taxes of $1,184 million as of both December 31, 2022 and March 25, 2023, $1,187 million as of June 17, 2023 and $1,189 million as of September 9, 2023. (b) Currency translation adjustment primarily reflects depreciation of the Egyptian pound and Russian ruble. (c) Release of currency translation adjustment is in relation to the sale of a non-strategic brand and an investment within our AMESA division. (d) Currency translation adjustment primarily reflects depreciation of the Russian ruble. (e) Currency translation adjustment primarily reflects appreciation of the euro, Mexican peso and South African rand, partially offset by the depreciation of the Russian ruble.
Reclassifications out of Accumulated Other Comprehensive Loss	The reclassifications from accumulated other comprehensive loss to the income statement are summarized as follows: 12 Weeks Ended 36 Weeks Ended 9/7/2024 9/9/2023 9/7/2024 9/9/2023 Affected Line Item in the Income Statement Currency translation: Divestitures $ — $ — $ — $ 108 Selling, general and administrative expenses Cash flow hedges: Foreign exchange contracts $ (1) $ — $ (1) $ (3) Net revenue Foreign exchange contracts (2) 26 16 44 Cost of sales Cross currency contracts and interest rate derivatives (24) 31 11 4 Selling, general and administrative expenses Commodity contracts 34 23 85 61 Cost of sales Commodity contracts — 1 — — Selling, general and administrative expenses Net losses before tax 7 81 111 106 Tax amounts (1) (20) (28) (27) Net losses after tax $ 6 $ 61 $ 83 $ 79 Pension and retiree medical items: Amortization of prior service credits $ (7) $ (8) $ (21) $ (23) Other pension and retiree medical benefits income Amortization of net losses 17 13 50 38 Other pension and retiree medical benefits income Settlement losses 15 — 17 — Other pension and retiree medical benefits income Net losses before tax 25 5 46 15 Tax amounts (5) (1) (9) (3) Net losses after tax $ 20 $ 4 $ 37 $ 12 Total net losses reclassified, net of tax $ 26 $ 65 $ 120 $ 199

Basis of Presentation and Our_4

Basis of Presentation and Our Divisions (Narrative) (Details) - segment	3 Months Ended		8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Basis Of Presentation And Our Divisions [Line Items]
Number of Reportable Segments			7
Disaggregation of Net Revenue - Beverages	44%	43%	43%	42%
Disaggregation of Net Revenue - Convenient Food	56%	57%	57%	58%
LatAm
Basis Of Presentation And Our Divisions [Line Items]
Disaggregation of Net Revenue - Beverages	10%	10%	10%	9%
Disaggregation of Net Revenue - Convenient Food	90%	90%	90%	91%
Europe
Basis Of Presentation And Our Divisions [Line Items]
Disaggregation of Net Revenue - Beverages	51%	50%	48%	49%
Disaggregation of Net Revenue - Convenient Food	49%	50%	52%	51%
AMESA
Basis Of Presentation And Our Divisions [Line Items]
Disaggregation of Net Revenue - Beverages	31%	31%	32%	31%
Disaggregation of Net Revenue - Convenient Food	69%	69%	68%	69%
APAC
Basis Of Presentation And Our Divisions [Line Items]
Disaggregation of Net Revenue - Beverages	26%	27%	23%	23%
Disaggregation of Net Revenue - Convenient Food	74%	73%	77%	77%
United States and Canada
Basis Of Presentation And Our Divisions [Line Items]
Fiscal Period Duration	84 days

Basis of Presentation and Our_5

Basis of Presentation and Our Divisions - Segment Reporting Information by Net Revenue (Details) - USD ($) $ in Millions	3 Months Ended		8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Revenue	$ 23,319	$ 23,453	$ 64,070	$ 63,621
FLNA
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Revenue	5,888	5,954	17,438	17,441
QFNA
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Revenue	648	747	1,802	2,208
PBNA
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Revenue	7,175	7,161	19,860	19,714
LatAm
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Revenue	2,915	3,055	8,027	7,688
Europe
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Revenue	3,946	3,704	9,397	9,018
AMESA
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Revenue	1,552	1,615	4,184	4,202
APAC
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Revenue	$ 1,195	$ 1,217	$ 3,362	$ 3,350

Basis of Presentation and Our_6

Basis of Presentation and Our Divisions - Segment Reporting Information by % of Disaggregated Net Revenue (Details)	3 Months Ended		8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Disaggregation of Revenue [Line Items]
Disaggregation of Net Revenue - Beverages	44%	43%	43%	42%
Disaggregation of Net Revenue - Convenient Food	56%	57%	57%	58%
Disaggregation of beverage revenue from company-owned bottlers	37%	36%	36%	36%
LatAm
Disaggregation of Revenue [Line Items]
Disaggregation of Net Revenue - Beverages	10%	10%	10%	9%
Disaggregation of Net Revenue - Convenient Food	90%	90%	90%	91%
Europe
Disaggregation of Revenue [Line Items]
Disaggregation of Net Revenue - Beverages	51%	50%	48%	49%
Disaggregation of Net Revenue - Convenient Food	49%	50%	52%	51%
AMESA
Disaggregation of Revenue [Line Items]
Disaggregation of Net Revenue - Beverages	31%	31%	32%	31%
Disaggregation of Net Revenue - Convenient Food	69%	69%	68%	69%
APAC
Disaggregation of Revenue [Line Items]
Disaggregation of Net Revenue - Beverages	26%	27%	23%	23%
Disaggregation of Net Revenue - Convenient Food	74%	73%	77%	77%

Basis of Presentation and Our_7

Basis of Presentation and Our Divisions - Segment Reporting Information by Operating Profit (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Segment Reporting Information [Line Items]
Operating Profit	$ 3,872	$ 4,015	$ 10,637	$ 10,303
Asset Impairment Charges, after-tax		86		86
Asset Impairment Charges		113	0	113
Product recall-related impact			184	0
Gain (Loss) on Disposition of Assets	76	85	76	85
Gain (Loss) on Disposition of Assets, After-Tax	$ 57	$ 65	$ 57	$ 65
Gain (Loss) on Disposition of Assets - per-share amount	$ 0.04	$ 0.05	$ 0.04	$ 0.05
Impairment Effect on Earnings Per Share, after Tax		$ 0.06		$ 0.06
Tropicana JV
Segment Reporting Information [Line Items]
Equity Method Investment, Ownership Percentage		39%		39%
Operating Segments
Segment Reporting Information [Line Items]
Operating Profit	$ 4,316	$ 4,503	$ 11,788	$ 11,643
Corporate
Segment Reporting Information [Line Items]
Operating Profit	(444)	(488)	(1,151)	(1,340)
FLNA | Operating Segments
Segment Reporting Information [Line Items]
Operating Profit	1,523	1,669	4,669	4,915
QFNA
Segment Reporting Information [Line Items]
Product recall-related impact			184
Product recall-related impact - after-tax			$ 141
Product recall-related impact - per-share amount			$ 0.10
QFNA | Cost of sales
Segment Reporting Information [Line Items]
Product recall-related impact			$ 174
QFNA | Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Product recall-related impact			7
QFNA | Pension charges associated with Quaker Recall
Segment Reporting Information [Line Items]
Product recall-related impact			3
QFNA | Operating Segments
Segment Reporting Information [Line Items]
Operating Profit	97	135	133	452
PBNA | Operating Segments
Segment Reporting Information [Line Items]
Operating Profit	914	970	2,411	2,176
LatAm | Operating Segments
Segment Reporting Information [Line Items]
Operating Profit	595	593	1,717	1,549
Europe | Operating Segments
Segment Reporting Information [Line Items]
Operating Profit	728	659	1,550	1,206
AMESA | Operating Segments
Segment Reporting Information [Line Items]
Operating Profit	197	238	590	656
APAC | Operating Segments
Segment Reporting Information [Line Items]
Operating Profit	$ 262	$ 239	$ 718	$ 689

Restructuring and Impairment _3

Restructuring and Impairment Charges - (Expected Pre-Tax Charges for 2019 Productivity Plan) (Details) - 2019 Productivity Plan $ in Millions	Sep. 07, 2024 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost	$ 3,650
Restructuring and Related Cost, Expected Cash Expenditures	$ 2,900
Severance and Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	55%
Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	10%
Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	35%
Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	15%
FLNA
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	10%
QFNA
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	1%
PBNA
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	30%
LatAm
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	10%
Europe
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	25%
AMESA
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	5%
APAC
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	4%

Restructuring and Impairment _4

Restructuring and Impairment Charges - (Summary of 2019 Productivity Plan Charges) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Restructuring Cost and Reserve [Line Items]
Cash payments			$ (284)	$ (283)
2019 Productivity Plan
Restructuring Cost and Reserve [Line Items]
Liability as of December 30, 2023			197
2024 restructuring charges	$ 245	$ 83	415	$ 287
Cash payments			(284)
Non-cash charges and translation			(29)
Liability as of September 7, 2024	$ 299		$ 299
Impact on net income attributable to PepsiCo per common share	$ (0.14)	$ (0.05)	$ (0.24)	$ (0.16)
Restructuring and Related Cost, Cost Incurred to Date	$ 2,315		$ 2,315
2019 Productivity Plan | FLNA
Restructuring Cost and Reserve [Line Items]
2024 restructuring charges	8	$ 6	43	$ 19
Restructuring and Related Cost, Cost Incurred to Date	295		295
2019 Productivity Plan | QFNA
Restructuring Cost and Reserve [Line Items]
2024 restructuring charges	0	0	4	0
Restructuring and Related Cost, Cost Incurred to Date	23		23
2019 Productivity Plan | PBNA
Restructuring Cost and Reserve [Line Items]
2024 restructuring charges	128	8	143	18
Restructuring and Related Cost, Cost Incurred to Date	410		410
2019 Productivity Plan | AMESA
Restructuring Cost and Reserve [Line Items]
2024 restructuring charges	4	5	7	10
Restructuring and Related Cost, Cost Incurred to Date	104		104
2019 Productivity Plan | APAC
Restructuring Cost and Reserve [Line Items]
2024 restructuring charges	2	2	6	7
Restructuring and Related Cost, Cost Incurred to Date	91		91
2019 Productivity Plan | LatAm
Restructuring Cost and Reserve [Line Items]
2024 restructuring charges	11	8	32	19
Restructuring and Related Cost, Cost Incurred to Date	232		232
2019 Productivity Plan | Europe
Restructuring Cost and Reserve [Line Items]
2024 restructuring charges	46	44	83	185
Restructuring and Related Cost, Cost Incurred to Date	649		649
Other than 2019 Productivity Plan
Restructuring Cost and Reserve [Line Items]
2024 restructuring charges			0
Corporate | 2019 Productivity Plan
Restructuring Cost and Reserve [Line Items]
2024 restructuring charges	39	10	75	30
Restructuring and Related Cost, Cost Incurred to Date	392		392
Severance and Other Employee Costs | 2019 Productivity Plan
Restructuring Cost and Reserve [Line Items]
Liability as of December 30, 2023			188
2024 restructuring charges	151	39	233	181
Cash payments			(131)
Non-cash charges and translation			(17)
Liability as of September 7, 2024	273		273
Restructuring and Related Cost, Cost Incurred to Date	1,283		1,283
Asset Impairments | 2019 Productivity Plan
Restructuring Cost and Reserve [Line Items]
Liability as of December 30, 2023			0
2024 restructuring charges	30	1	34	1
Cash payments			0
Non-cash charges and translation			(34)
Liability as of September 7, 2024	0		0
Restructuring and Related Cost, Cost Incurred to Date	226		226
Other Costs | 2019 Productivity Plan
Restructuring Cost and Reserve [Line Items]
Liability as of December 30, 2023			9
2024 restructuring charges	64	43	148	105
Cash payments			(153)
Non-cash charges and translation			22
Liability as of September 7, 2024	26		26
Restructuring and Related Cost, Cost Incurred to Date	806		806
Cost of sales | 2019 Productivity Plan
Restructuring Cost and Reserve [Line Items]
2024 restructuring charges	10	4	16	10
Selling, general and administrative expenses | 2019 Productivity Plan
Restructuring Cost and Reserve [Line Items]
2024 restructuring charges	228	79	377	278
Other pension and retiree medical benefits expense/(income) (a) | 2019 Productivity Plan
Restructuring Cost and Reserve [Line Items]
2024 restructuring charges	7	0	22	(1)
Restructuring and Related Cost, Cost Incurred to Date	119		119
Restructuring, Settlement and Impairment Provisions, less Other pension and retiree medical benefits expense | 2019 Productivity Plan
Restructuring Cost and Reserve [Line Items]
2024 restructuring charges	238	83	393	288
Restructuring and Related Cost, Cost Incurred to Date	2,196		2,196
After-tax amount | 2019 Productivity Plan
Restructuring Cost and Reserve [Line Items]
2024 restructuring charges	$ 195	$ 67	$ 325	$ 228

Intangible Assets - Schedule of

Intangible Assets - Schedule of Finite-Lived Intangible Assets (Detail) - USD ($) $ in Millions	Sep. 07, 2024	Dec. 30, 2023
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 2,912	$ 2,942
Accumulated Amortization	(1,780)	(1,743)
Amortizable Intangible Assets, net	1,132	1,199
Acquired Franchise Rights
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	836	840
Accumulated Amortization	(224)	(214)
Amortizable Intangible Assets, net	612	626
Reacquired Franchise Rights
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	561	560
Accumulated Amortization	(284)	(265)
Amortizable Intangible Assets, net	277	295
Brands
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	1,087	1,093
Accumulated Amortization	(996)	(989)
Amortizable Intangible Assets, net	91	104
Other identifiable intangibles
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	428	449
Accumulated Amortization	(276)	(275)
Amortizable Intangible Assets, net	$ 152	$ 174

Intangible Assets - Schedule _2

Intangible Assets - Schedule of Change in Book Value of Indefinite-Lived Intangible Assets (Detail) $ in Millions	8 Months Ended
	Sep. 07, 2024 USD ($)
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	$ 31,458
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	(24)
Balance 9/7/2024	31,434
FLNA
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	704
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	(2)
Balance 9/7/2024	702
QFNA
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	189
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	0
Balance 9/7/2024	189
PBNA
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	23,320
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	(25)
Balance 9/7/2024	23,295
AMESA
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	1,128
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	23
Balance 9/7/2024	1,151
APAC
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	712
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	0
Balance 9/7/2024	712
LatAm
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	542
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	(35)
Balance 9/7/2024	507
Europe
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	4,863
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	15
Balance 9/7/2024	4,878
Goodwill
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	17,728
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	(19)
Balance 9/7/2024	17,709
Goodwill | FLNA
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	453
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	(2)
Balance 9/7/2024	451
Goodwill | QFNA
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	189
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	0
Balance 9/7/2024	189
Goodwill | PBNA
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	11,961
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	(8)
Balance 9/7/2024	11,953
Goodwill | AMESA
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	991
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	17
Balance 9/7/2024	1,008
Goodwill | APAC
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	508
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	0
Balance 9/7/2024	508
Goodwill | LatAm
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	460
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	(29)
Balance 9/7/2024	431
Goodwill | Europe
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	3,166
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	3
Balance 9/7/2024	3,169
Brands
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	4,306
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	20
Balance 9/7/2024	4,326
Brands | FLNA
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	251
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	0
Balance 9/7/2024	251
Brands | PBNA
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	2,508
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	0
Balance 9/7/2024	2,508
Brands | AMESA
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	137
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	6
Balance 9/7/2024	143
Brands | APAC
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	204
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	0
Balance 9/7/2024	204
Brands | LatAm
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	82
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	(6)
Balance 9/7/2024	76
Brands | Europe
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	1,124
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	20
Balance 9/7/2024	1,144
Reacquired franchise rights
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	7,533
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	(12)
Balance 9/7/2024	7,521
Reacquired franchise rights | PBNA
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	7,114
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	(14)
Balance 9/7/2024	7,100
Reacquired franchise rights | Europe
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	419
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	2
Balance 9/7/2024	421
Acquired franchise rights
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	1,891
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	(13)
Balance 9/7/2024	1,878
Acquired franchise rights | PBNA
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	1,737
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	(3)
Balance 9/7/2024	1,734
Acquired franchise rights | Europe
Indefinite-lived Intangible Assets [Line Items]
Balance 12/30/2023	154
Indefinite-lived Intangible Assets [Roll Forward]
Translation and Other	(10)
Balance 9/7/2024	$ 144

Income Taxes Narrative (Details

Income Taxes Narrative (Details)	3 Months Ended
	Sep. 07, 2024
Income Tax Disclosure [Abstract]
Global Minimum Tax	0.15

Share-Based Compensation - Weig

Share-Based Compensation - Weighted Average Black Scholes Fair Value Assumptions (Detail)	8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023
Black Scholes valuation assumptions [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	7 years	7 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	4.20%	4.20%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	16%	16%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	2.90%	2.70%

Share-Based Compensation - Addi

Share-Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Recognized stock-based compensation expense	$ 77	$ 88	$ 260	$ 267
Compensation cost for share-based liabilities	4	7	14	19
Share-based Payment Arrangement, Expensed and Capitalized, Amount	80	95	269	286
Share based liability awards granted, target			19	20
Share-based Compensation
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restructuring and impairment charges	$ (1)	$ 0	$ (5)	$ 0
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			2	2.1
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Price			$ 164.28	$ 171.83
RSUs and PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			2.3	2.1
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other Than Options, Grants in Period, Weighted Average Grant Price			$ 164.25	$ 171.11

Pension and Retiree Medical B_3

Pension and Retiree Medical Benefits - Net Periodic Benefit Cost (Details) - USD ($) $ in Millions	3 Months Ended		8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Service Cost	$ 80	$ 76	$ 240	$ 227
Defined Benefit Plan, Interest Cost	135	137	405	411
Defined Benefit Plan, Expected Return (Loss) on Plan Assets	(201)	(197)	(604)	(590)
Defined Benefit Plan, Amortization of Prior Service Cost (Credit)	(6)	(6)	(17)	(18)
Defined Benefit Plan, Amortization of Gain (Loss)	17	16	53	48
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), (Gain) Loss Due to Settlement	8	0	8	0
Defined Benefit Plan, Benefit Obligation, Special and Contractual Termination Benefits				(1)
Defined Benefit Plan, Cost of Providing Special and Contractual Termination Benefits	8	0	23
Defined Benefit Plan, Other Cost (Credit)	(39)	(50)	(132)	(150)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Total	41	26	108	77
Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Service Cost	11	10	32	28
Defined Benefit Plan, Interest Cost	36	34	99	93
Defined Benefit Plan, Expected Return (Loss) on Plan Assets	(50)	(45)	(139)	(126)
Defined Benefit Plan, Amortization of Prior Service Cost (Credit)	0	(1)	(1)	(1)
Defined Benefit Plan, Amortization of Gain (Loss)	6	3	15	8
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), (Gain) Loss Due to Settlement	7	0	9	0
Defined Benefit Plan, Cost of Providing Special and Contractual Termination Benefits	0	0	0	0
Defined Benefit Plan, Other Cost (Credit)	(1)	(9)	(17)	(26)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Total	10	1	15	2
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Service Cost	7	7	22	20
Defined Benefit Plan, Interest Cost	7	7	22	24
Defined Benefit Plan, Expected Return (Loss) on Plan Assets	(3)	(3)	(9)	(9)
Defined Benefit Plan, Amortization of Prior Service Cost (Credit)	(1)	(1)	(3)	(4)
Defined Benefit Plan, Amortization of Gain (Loss)	(6)	(6)	(18)	(18)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), (Gain) Loss Due to Curtailment	0	0	0	0
Defined Benefit Plan, Cost of Providing Special and Contractual Termination Benefits	2	0	2	0
Defined Benefit Plan, Other Cost (Credit)	(1)	(3)	(6)	(7)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Total	$ 6	$ 4	$ 16	$ 13

Pension and Retiree Medical B_4

Pension and Retiree Medical Benefits - Narrative (Details) - USD ($) $ in Millions	8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023
Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Contributions by Employer	$ 150	$ 250
Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Contributions by Employer	$ 27	$ 17

Debt Obligations - Summary of S

Debt Obligations - Summary of Senior Notes (Detail) $ in Millions	Sep. 07, 2024 USD ($)
Notes Due 2027 | Floating Rate Percent Notes due 2027
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 300
Notes Due 2027 | Four Point Six Five Percent Notes due 2027
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	4.65%
Debt Instrument, Face Amount	$ 550
Notes Due 2029 | Four Point Five Five Percent Notes due 2029
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	4.55%
Debt Instrument, Face Amount	$ 450
Notes Due 2029 | Four Point Five Percent Notes due 2029
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	4.50%
Debt Instrument, Face Amount	$ 850
Notes Due 2034 | Four Point Seven Percent Notes due 2034
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	4.70%
Debt Instrument, Face Amount	$ 450
Notes Due 2034 | Four Point Eight Percent Notes due 2034
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	4.80%
Debt Instrument, Face Amount	$ 650
Notes Due 2054 | Five Point Two Five Percent Notes due 2054
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	5.25%
Debt Instrument, Face Amount	$ 750

Debt Obligations - (Narrative)

Debt Obligations - (Narrative) (Details) € in Millions, $ in Millions, $ in Millions	Sep. 07, 2024 USD ($)	Sep. 07, 2024 EUR (€)	Sep. 07, 2024 CAD ($)	Sep. 09, 2023 USD ($)
Debt Instrument [Line Items]
Long-term Debt, Current Maturities	$ 1,300	€ 1,000	$ 800
Commercial Paper	2,000
Line of Credit Facility, Outstanding Borrowings	0
Five Year Unsecured Revolving Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity	5,000			$ 4,200
Line of Credit Facility, Maximum Borrowing Capacity	5,750
Line of Credit Swing Line Subfacility	750
364 Day Unsecured Revolving Credit Agreement Member
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity	5,000			$ 4,200
Line of Credit Facility, Maximum Borrowing Capacity	$ 5,750

Financial Instruments - Celsius

Financial Instruments - Celsius (Detail) - USD ($) $ in Millions	3 Months Ended	8 Months Ended
	Sep. 07, 2024	Sep. 07, 2024	Sep. 09, 2023	Dec. 30, 2023
Celsius [Line Items]
Impairment Losses, Investments, Available-for-Sale Securities1		$ 0	$ 0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	$ (453)	(265)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)	$ (7)	$ (14)
Significant unobservable input used in level 3 fair value measurement - Celsius	5.80%	5.80%		8.10%
Significant unobservable input used in level 3 fair value measurement - Celsius, probability assumption	80%	80%		80%
Debt Security, Available-for-sale, Level 3			0
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	$ 347	$ 347	$ 0

Financial Instruments - Additio

Financial Instruments - Additional Information (Detail) - USD ($)	8 Months Ended	12 Months Ended
	Sep. 07, 2024	Dec. 30, 2023
Derivatives, Fair Value [Line Items]
Cross Currency Interest Rate Swap Notional for Chinese Renminbi	$ 500,000,000
Derivative with Credit Risk Related Contingent Features, Net Liability Position, Aggregate Fair Value	171,000,000
Debt Instrument, Fair Value Disclosure	42,000,000,000	$ 41,000,000,000
Expected reclassification of net gain/(losses) related to hedge from accumulated OCI into net income within the next 12 months	(62,000,000)
Collateral Already Posted, Aggregate Fair Value	0
Credit-Risk-Related Contingent Features Triggered	$ 0
Gross Unrecognized (Gains) and Losses	not material	not material
Debt Securities, Held-to-Maturity, Allowance for Credit Loss	not material	not material
Debt Securities, Held-to-maturity	$ 46,000,000
Commercial Paper
Derivatives, Fair Value [Line Items]
Debt Securities, Held-to-maturity		$ 309,000,000
Variable Rate [Domain]
Derivatives, Fair Value [Line Items]
Total Debt, Percentage Bearing Variable Interest, Percentage Rate	9%	9%

Financial Instruments - Notiona

Financial Instruments - Notional Amounts of Financial Instruments (Detail) - USD ($) $ in Billions	Sep. 07, 2024	Dec. 30, 2023
Non-derivative Debt Instruments
Derivatives [Line Items]
Non-derivative Debt Instruments	$ 3.1	$ 3
Commodity Contract [Member]
Derivatives [Line Items]
Derivative, Notional Amount	1.4	1.7
Foreign Exchange Contract
Derivatives [Line Items]
Derivative, Notional Amount	3.1	3.8
Cross Currency Interest Rate Contract [Member]
Derivatives [Line Items]
Derivative, Notional Amount	$ 1.2	$ 1.3

Financial Instruments - Fair Va

Financial Instruments - Fair Values of Financial Assets and Liabilities (Detail) - USD ($) $ in Millions	8 Months Ended	12 Months Ended
	Sep. 07, 2024	Dec. 30, 2023
Derivatives, Fair Value [Line Items]
Short-term Investments	$ 743	$ 292
Derivative Liability	201	241
Derivative Asset	59	56
Total Financial Assets At Fair Value	1,455	1,695
Total Financial Liabilities At Fair Value	$ 691	$ 718
Collateral Received or Posted against our Asset or Liability Positions	not material
Derivative Assets and Liabilities, Subject to Master Netting Arrangements, which are not offset on balance sheet.	not material	not material
Derivatives Designated As Cash Flow Hedging Instruments Assets
Derivatives, Fair Value [Line Items]
Derivatives designated as hedging instruments, Assets, Total	$ 39	$ 18
Derivatives Designated As Cash Flow Hedging Instruments Liabilities
Derivatives, Fair Value [Line Items]
Derivatives designated as hedging instruments, Liabilities, Total	165	190
Derivatives Not Designated As Hedging Instruments Assets
Derivatives, Fair Value [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	20	38
Derivatives Not Designated As Hedging Instruments Liabilities
Derivatives, Fair Value [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	23	51
Derivatives Designated As Net Investment Hedging Instruments Assets
Derivatives, Fair Value [Line Items]
Derivative Instruments in Hedges, Assets, at Fair Value	0	0
Derivatives Designated As Net Investment Hedging Instruments Liabilities
Derivatives, Fair Value [Line Items]
Derivative Instruments in Hedges, Liabilities, at Fair Value	13	0
Assets | Cross Currency Interest Rate Contract [Member]
Derivatives, Fair Value [Line Items]
Cross-Currency Contracts	0	0
Liability | Cross Currency Interest Rate Contract [Member]
Derivatives, Fair Value [Line Items]
Cross-Currency Contracts	13	0
Fair Value, Inputs, Level 2
Derivatives, Fair Value [Line Items]
Debt Securities, Available-for-Sale	184	178
Fair Value, Inputs, Level 2 | Derivatives Designated As Cash Flow Hedging Instruments Assets
Derivatives, Fair Value [Line Items]
Foreign Exchange Forward contracts	35	3
Cross-Currency Contracts	0	5
Commodity contracts - other	4	10
Fair Value, Inputs, Level 2 | Derivatives Designated As Cash Flow Hedging Instruments Liabilities
Derivatives, Fair Value [Line Items]
Foreign Exchange Forward contracts	11	31
Cross-Currency Contracts	138	135
Commodity contracts - other	16	24
Fair Value, Inputs, Level 2 | Derivatives Not Designated As Hedging Instruments Assets
Derivatives, Fair Value [Line Items]
Foreign Exchange Forward contracts	17	33
Commodity contracts - other	3	5
Fair Value, Inputs, Level 2 | Derivatives Not Designated As Hedging Instruments Liabilities
Derivatives, Fair Value [Line Items]
Foreign Exchange Forward contracts	14	38
Commodity contracts - other	9	13
Fair Value, Inputs, Level 2 | Assets
Derivatives, Fair Value [Line Items]
Prepaid Forward Contract Fair Value	17	13
Deferred compensation	0	0
Fair Value, Inputs, Level 2 | Liability
Derivatives, Fair Value [Line Items]
Prepaid Forward Contract Fair Value	0	0
Deferred compensation	490	477
Fair Value, Inputs, Level 1 | Assets
Derivatives, Fair Value [Line Items]
Short-term Investments	318	292
Fair Value, Inputs, Level 1 | Liability
Derivatives, Fair Value [Line Items]
Short-term Investments	0	0
Fair Value, Inputs, Level 3
Derivatives, Fair Value [Line Items]
Debt Securities, Available-for-Sale	877	1,156
Fair Value, Inputs, Level 2 and Level 3 | Assets
Derivatives, Fair Value [Line Items]
Debt Securities, Available-for-Sale	1,061	1,334
Fair Value, Inputs, Level 2 and Level 3 | Liability
Derivatives, Fair Value [Line Items]
Debt Securities, Available-for-Sale	0	0
Fair Value, Inputs, Level 2 and Level 3 | Other Assets
Derivatives, Fair Value [Line Items]
Debt Securities, Available-for-Sale	$ 1,061	$ 1,334

Financial Instruments - Losses

Financial Instruments - Losses (Gains) On Derivative Instruments - Cash-flow Hedges (Detail) - USD ($) $ in Millions	3 Months Ended						8 Months Ended
	Sep. 07, 2024	Jun. 15, 2024	Mar. 23, 2024	Sep. 09, 2023	Jun. 17, 2023	Mar. 25, 2023	Sep. 07, 2024	Sep. 09, 2023
Derivative Instruments, Loss (Gain) [Line Items]
Other Comprehensive (Income) Loss, (Gain) Loss, before Reclassification and Tax	$ 34	$ (3)	$ 47	$ 96	$ (19)	$ 92
Foreign exchange contracts | Cash Flow Hedging [Member]
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	(3)			26			$ 15	$ 41
Other Comprehensive (Income) Loss, (Gain) Loss, before Reclassification and Tax	(33)			15			(48)	74
Commodity Contract [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	34			24			85	61
Other Comprehensive (Income) Loss, (Gain) Loss, before Reclassification and Tax	75			65			103	115
Cash Flow Hedging [Member]
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	10			81			114	106
Other Comprehensive (Income) Loss, (Gain) Loss, before Reclassification and Tax	27			103			74	186
Cross Currency Interest Rate Contract [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	(21)			31			14	4
Other Comprehensive (Income) Loss, (Gain) Loss, before Reclassification and Tax	$ (15)			$ 23			$ 19	$ (3)

Financial Instruments - TBG Imp

Financial Instruments - TBG Impairment (Detail) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	8 Months Ended
	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Derivative Instruments, Loss (Gain) [Line Items]
Asset Impairment Charges, after-tax	$ 86		$ 86
Asset Impairment Charges	$ 113	$ 0	$ 113
Impairment Effect on Earnings Per Share, after Tax	$ 0.06		$ 0.06
Tropicana JV
Derivative Instruments, Loss (Gain) [Line Items]
Equity Method Investment, Ownership Percentage	39%		39%

Financial Instruments - Losse_2

Financial Instruments - Losses (Gains) Recognized in the Income Statement - Non-designated Hedges (Detail) - USD ($) $ in Millions	3 Months Ended		8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Nondesignated Hedges
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	$ 53	$ (81)	$ 60	$ 46
Nondesignated Hedges - Selling, General and Administrative Expenses
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	28	(72)	50	20
Nondesignated Hedges - Cost of Sales
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	25	(9)	10	26
Foreign Exchange Contract Losses/(Gains) Included in Cost of Sales | Nondesignated Hedges - Cost of Sales
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	1	0	1	(1)
Foreign Exchange Contract Losses/(Gains) Included in Selling, General and Administrative Expenses | Nondesignated Hedges - Selling, General and Administrative Expenses
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	(8)	(7)	34	32
Foreign exchange contracts | Nondesignated Hedges
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	(7)	(7)	35	31
Commodity Contract Losses/(Gains) Included in Cost of Sales | Nondesignated Hedges - Cost of Sales
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	24	(9)	9	27
Commodity Contract Losses/(Gains) Included in Selling, General and Administrative Expenses | Nondesignated Hedges - Selling, General and Administrative Expenses
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	36	(65)	16	(12)
Commodity Contract [Member] | Nondesignated Hedges
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	$ 60	$ (74)	$ 25	$ 15

Financial Instruments - Losse_3

Financial Instruments - Losses (Gains) on Derivative Instruments - Net Investment Hedges (Detail) - Net Investment Hedging [Member] - USD ($) $ in Millions	3 Months Ended		8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Derivative Instruments, Loss (Gain) [Line Items]
Other Comprehensive (Income) Loss, Net Investment Hedge, (Gain) Loss, before Tax	$ 127	$ (68)	$ 58	$ 40
Loss (Gain) on Net Investment Hedge Recognized in Net Income, Net, Pretax	(2)	0	(2)	0
Debt Instruments
Derivative Instruments, Loss (Gain) [Line Items]
Other Comprehensive (Income) Loss, Net Investment Hedge, (Gain) Loss, before Tax	114	(68)	45	40
Loss (Gain) on Net Investment Hedge Recognized in Net Income, Net, Pretax	0	0	0	0
Cross Currency Interest Rate Contract [Member]
Derivative Instruments, Loss (Gain) [Line Items]
Other Comprehensive (Income) Loss, Net Investment Hedge, (Gain) Loss, before Tax	13	0	13	0
Loss (Gain) on Net Investment Hedge Recognized in Net Income, Net, Pretax	$ (2)	$ 0	$ (2)	$ 0

Net Income Attributable to Pe_3

Net Income Attributable to PepsiCo per Common Share - Basic And Diluted Net Income Per Common Share (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		8 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Earnings Per Share [Abstract]
Earnings Per Share, Basic (in USD per share)	$ 2.13	$ 2.25	$ 5.86	$ 5.64
Net Income (Loss) Available to Common Stockholders, Basic	$ 2,930	$ 3,092	$ 8,055	$ 7,772
Weighted Average Number of Shares Outstanding, Basic (in shares)	1,373	1,376	1,374	1,377
Dilutive Securities [Abstract]
Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units	$ 0	$ 0	$ 0	$ 0
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	5	7	5	7
Net Income (Loss) Available to Common Stockholders, Diluted	$ 2,930	$ 3,092	$ 8,055	$ 7,772
Weighted Average Number of Shares Outstanding, Diluted	1,378	1,383	1,379	1,384
Earnings Per Share, Diluted (in USD per share)	$ 2.13	$ 2.24	$ 5.84	$ 5.62
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	4		4

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss Attributable to PepsiCo - Schedule of Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Millions	3 Months Ended						8 Months Ended
	Sep. 07, 2024	Jun. 15, 2024	Mar. 23, 2024	Sep. 09, 2023	Jun. 17, 2023	Mar. 25, 2023	Sep. 07, 2024	Sep. 09, 2023	Dec. 30, 2023	Dec. 31, 2022
Statement of Other Comprehensive Income [Abstract]
Beginning balance	$ (13,704)	$ (13,437)	$ (13,255)	$ (13,381)	$ (13,183)	$ (12,948)	$ (13,255)	$ (12,948)
Other comprehensive (loss) before reclassifications (b)	(544)	(295)	(168)	19	(215)	(350)
Amounts reclassified from accumulated other comprehensive loss (c)	0	0	0	0	0	108	0	108
Net other comprehensive (loss)	(544)	(295)	(168)	19	(215)	(242)
Tax amounts	32	28	(14)	(17)	17	7
Ending balance	(14,216)	(13,704)	(13,437)	(13,379)	(13,381)	(13,183)	(14,216)	(13,379)
Beginning balance	14	(28)	(31)	(34)	(58)	1	(31)	1
Other comprehensive (loss) before reclassifications (b)	(34)	3	(47)	(96)	19	(92)
Amounts reclassified from accumulated other comprehensive loss (c)	7	53	51	81	12	13	111	106
Net other comprehensive (loss)	(27)	56	4	(15)	31	(79)
Tax amounts	3	(14)	(1)	4	(7)	20
Ending balance	(10)	14	(28)	(45)	(34)	(58)	(10)	(45)
Beginning balance	2,699	2,708	2,719	2,371	2,365	2,361	2,719	2,361
Other comprehensive (loss)/income before reclassifications (d)	0	(1)	4	(15)	(14)	(9)
Amounts reclassified from accumulated other comprehensive loss	25	12	9	5	5	5	46	15
Net other comprehensive (loss)/income	25	11	13	(10)	(9)	(4)
Tax amounts	(4)	(2)	(2)	2	3	0
Ending balance	2,678	2,699	2,708	2,379	2,371	2,365	2,678	2,379
Beginning balance	603	994	471	6	5	6	471	6
Other comprehensive income/(loss) before reclassifications (e)	(460)	(511)	685	3	1	(1)
Amounts reclassified from accumulated other comprehensive loss	0	0	0	0	0	0
Net other comprehensive income/(loss)	(460)	(511)	685	3	1	(1)
Tax amounts	109	120	(162)	0	0	0
Ending balance	252	603	994	9	6	5	252	9
OCI, before Reclassifications, before Tax, Attributable to Parent	(1,038)	(804)	474	(89)	(209)	(452)
Reclassification from AOCI, Current Period, before Tax, Attributable to Parent	32	65	60	86	17	126
Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent	(1,006)	(739)	534	(3)	(192)	(326)
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent	140	132	(179)	(11)	13	27
Accumulated Other Comprehensive Income (Loss), Net of Tax	(16,652)	(15,786)	(15,179)	(15,794)	(15,780)	(15,601)	$ (16,652)	(15,794)	$ (15,534)	$ (15,302)
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]							Selling, general and administrative expenses
Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Post retirement Plans Taxes	1,274	1,278	1,280	1,189	1,187	1,184	$ 1,274	1,189	1,282	1,184
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items]
Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Post retirement Plans Taxes	1,274	$ 1,278	$ 1,280	1,189	$ 1,187	$ 1,184	1,274	1,189	$ 1,282	$ 1,184
Cross Currency Interest Rate Contract [Member] | Cash Flow Hedging [Member]
Statement of Other Comprehensive Income [Abstract]
Other comprehensive (loss) before reclassifications (b)	15			(23)			(19)	3
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items]
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	(21)			31			14	4
Tropicana JV | Cross Currency Interest Rate Contract [Member] | Cash Flow Hedging [Member]
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items]
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	$ (24)			$ 31			$ 11	$ 4

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss Attributable to PepsiCo - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended						8 Months Ended
	Sep. 07, 2024	Jun. 15, 2024	Mar. 23, 2024	Sep. 09, 2023	Jun. 17, 2023	Mar. 25, 2023	Sep. 07, 2024	Sep. 09, 2023
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items]
Amounts reclassified from accumulated other comprehensive loss (c)	$ 0	$ 0	$ 0	$ 0	$ 0	$ 108	$ 0	$ 108
Cash flow hedges:
Amounts reclassified from accumulated other comprehensive loss (c)	7	53	51	81	12	13	111	106
Tax amounts	(1)			(20)			(28)	(27)
Net losses after tax	6			61			83	79
Pension and retiree medical items:
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax	(7)			(8)			(21)	(23)
Amortization of net losses	17			13			50	38
Settlement losses	15			0			17	0
Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax	25	12	9	5	5	5	46	15
Tax amounts	(5)			(1)			(9)	(3)
Net losses after tax	20			4			37	12
Total net losses reclassified, net of tax	26			65			120	199
Net other comprehensive (loss)	(27)	56	4	(15)	31	(79)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	(7)	$ (53)	$ (51)	(81)	$ (12)	$ (13)	(111)	(106)
Tax amounts	(1)			(20)			(28)	(27)
Net losses after tax	6			61			83	79
Cash Flow Hedging [Member] | Foreign exchange contracts
Cash flow hedges:
Losses/(gains) on cash flow hedges	(3)			26			15	41
Cash Flow Hedging [Member] | Foreign exchange contracts | Revenue, Net
Cash flow hedges:
Losses/(gains) on cash flow hedges	(1)			0			(1)	(3)
Cash Flow Hedging [Member] | Foreign exchange contracts | Cost of sales
Cash flow hedges:
Losses/(gains) on cash flow hedges	(2)			26			16	44
Cash Flow Hedging [Member] | Commodity contracts
Cash flow hedges:
Losses/(gains) on cash flow hedges	34			24			85	61
Cash Flow Hedging [Member] | Commodity contracts | Cost of sales
Cash flow hedges:
Losses/(gains) on cash flow hedges	34			23			85	61
Cash Flow Hedging [Member] | Commodity contracts | Selling, general and administrative expenses
Cash flow hedges:
Losses/(gains) on cash flow hedges	$ 0			$ 1			$ 0	$ 0

Acquisitions & Divestitures - S

Acquisitions & Divestitures - Summary of Income Statement (Juice Transaction) (Details)	Sep. 09, 2023
Tropicana JV
Acquisitions & Divestitures [Line Items]
Equity Method Investment, Ownership Percentage	39%

Supply Chain Financing (Details

Supply Chain Financing (Details) - USD ($) $ in Billions	Sep. 07, 2024	Dec. 30, 2023
Text Block [Abstract]
Supplier Finance Program, Obligation, Current	$ 1.6	$ 1.7

Subsequent Events (Details)

Subsequent Events (Details) $ in Millions	Oct. 01, 2024 USD ($)
Subsequent Event [Member]
Subsequent Event [Line Items]
Payments to Acquire Businesses, Gross	$ 1,200